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ABSTRACT 
The mitochondrial respiratory chain (MRC) consists of four large protein 
complexes that catalyze redox reactions driving cellular energy production. These 
complexes assemble into supra-molecular structures called supercomplexes in the 
mitochondrial inner membrane. Mitochondrial membrane phospholipid composition is 
unique and highly conserved, with the bilayer-forming phosphatidylcholine (PC) and 
non-bilayer forming phosphatidylethanolamine (PE) and cardiolipin (CL) being the most 
abundant phospholipids. Previous studies highlighted the critical role of CL in MRC 
supercomplex formation, however, the roles of PE and PC, remained poorly understood. 
To address this gap in our knowledge, I utilized the yeast Saccharomyces cerevisiae as a 
model organism to dissect the role of PE and PC in MRC biogenesis.  
By performing biochemical analysis of yeast mutants of PC, PE and CL 
biosynthesis, I discovered a specific requirement for non-bilayer forming phospholipids 
in MRC biogenesis. Specifically, I showed that PE is required for MRC complex III and 
IV activities, whereas the loss of the most abundant phospholipid PC does not affect 
MRC function. Unlike CL, neither PE nor PC is required for MRC supercomplex 
formation. Furthermore, I found that the loss of mitochondrial PE biosynthesis could be 
compensated by exogenous supplementation of ethanolamine, a PE precursor, 
suggesting the existence of a mitochondrial PE import pathway. 
The non-bilayer phospholipids PE and CL have been proposed to have overlapping 
functions, raising an intriguing possibility that elevating mitochondrial PE may 
compensate for CL deficiency. To test this hypothesis, I utilized an ethanolamine 
iii 
supplementation strategy and demonstrated that ethanolamine rescues the respiratory 
growth of CL deficient cells by promoting MRC supercomplexes. Surprisingly, the 
rescue was independent of PE biosynthesis and was solely dependent on ethanolamine. 
This exciting finding has important biomedical implications in the treatment of Barth 
syndrome, a rare genetic disorder characterized by CL deficiency.  
Finally, I describe how the inhibition of non-mitochondrial PE biosynthesis by 
meclizine, an over-the-counter anti-nausea drug, attenuates respiration by elevating 
phosphoethanolamine, a PE precursor. Together, the research presented in this 
dissertation uncovers the specific roles of phospholipids in MRC biogenesis and 
describes novel approaches for manipulating MRC function that can be utilized for the 
treatment of mitochondrial disorders. 
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NOMENCLATURE 
MRC Mitochondrial Respiratory Chain 
ATP Adenosine Triphosphate 
ADP  Adenosine Diphosphate 
PE Phosphatidylethanolamine 
CL Cardiolipin 
PC Phosphatidylcholine 
PI Phosphatidylinositol 
PS Phosphatidylserine 
PA Phosphatidic Acid 
PG Phosphatidylglycerol 
PP Phosphatidylpropanolamine 
PDME Phosphatidyldimethylethanolamine 
PMME Phosphatidylmonomethylethanolamine 
MLCL Monolysocardiolipin 
Etn Ethanolamine 
PEtn Phosphoethanolamine 
Cho Choline 
PCho Phosphocholine 
Prn Propanolamine 
BTHS Barth Syndrome  
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 Mitochondria are ancient organelles that are a defining feature of the eukaryotic 
cell, performing many important cellular functions including energy production. The 
mitochondria are double membrane bound structures consisting of a highly permeable 
outer membrane and an ion impermeable inner membrane. The inner membrane is 
characterized by the presence of distinctive folds called cristae; customized structures 
that house and influence the function of the mitochondrial respiratory chain (MRC) 
(Cogliati et al., 2013). The MRC consists of four protein complexes that perform 
essential redox reactions by transferring electrons from nutrients to molecular oxygen 
and, in the process, generates the electrochemical gradient that drives ATP synthesis. 
While mitochondrial bioenergetics has been studied for decades, the role of the native 
membrane environment in MRC function and formation has not been investigated in a 
systematic manner (Schug et al., 2012).  
Mitochondrial Energy Production 
The MRC is composed of four multimeric protein complexes that are assembled 
within the inner mitochondrial membrane (Fig. 1.1). In humans complex I, or 
nicotinamide adenine dinucleotide (NADH) dehydrogenase, is composed of 46 protein 
subunits (Scarpulla, 2008), whereas in yeast three single polypeptide enzymes replace 
this massive protein complex (Fig. 1.1) (Joseph-Horne et al., 2001). However, across 
evolution, the function of NADH dehydrogenase remains the same, to transfer electrons 
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from NADH to ubiquinone, or Coenzyme Q, reducing this two-electron carrier to 
ubiquinol. Complex II consists of four subunits in both yeast and humans and, like 
complex I, also donates electrons to ubiquinone, but does so through the oxidation of 
succinate. Ubiquinol diffuses readily through the membrane and delivers electrons to 
complex III. The function of complex III, or cytochrome c reductase, is to accept 
electrons from ubiquinol and reduce cytochrome c, a single electron carrier. Cytochrome 
c delivers electrons to complex IV, where they are ultimately accepted by molecular 
oxygen reducing it to water. Together the activities of MRC complexes I-IV result in 
oxygen consumption, or respiration, a parameter that is measured to assess MRC 
function.  
The activity of the MRC results in the translocation of protons across the inner 
mitochondrial membrane, which generates an electrochemical gradient that drives the 
activity of complex V, or ATP synthase. In higher eukaryotes, the redox reactions 
performed by complexes I, III, and IV result in the pumping of protons into the 
mitochondrial intermembrane space - whereas, in yeast, only complexes III and IV pump 
protons (Fig. 1.1). Complex V is able to harness the energy from the difference in 
membrane potential to synthesize ATP by transporting protons from the intermembrane 
space back into the mitochondrial matrix. Thus, ATP synthase couples respiration to 
energy production by harnessing the electrochemical gradient. Any disruption in MRC 
biogenesis results in reduced respiration, decreased membrane potential, and diminished 
ATP production, parameters that are often measured to assess MRC function. 
Perturbation in MRC function occasionally results in electron leakage and is frequently 
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associated with elevated reactive oxygen species and increased oxidative stress (Willems 
et al., 2015).  
Figure 1.1 Mitochondrial respiratory chain is the main site of cellular respiration and ATP 
production. 
(A) Depiction of mammalian and (B) yeast mitochondrial respiratory chain complexes 
embedded in the inner mitochondrial membrane. 
Within the mitochondrial inner membrane, MRC complexes interact in different 
stoichiometries and assemble into supra-molecular structures known as supercomplexes 
(Dudkina et al., 2011; Schagger and Pfeiffer, 2000). Schagger and colleagues first 
described supercomplexes through their employment of blue native polyacrylamide gel 
electrophoresis (Schagger and Pfeiffer, 2000). Although initially the presence of 
supercomplexes in vivo was controversial, later studies demonstrated their existence in a 
variety of organisms across evolution (Table 1.1). Recently, cryo-electron microscopy 
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was utilized to determine the structures of supercomplexes, thus, unequivocally proving 
their existence (Althoff et al., 2011; Dudkina et al., 2011; Wu et al., 2016; Letts et al., 
2016). 
Table 1.1 Identified respiratory supercomplexes by EM (O) and BN-page (X) 
(Data obtained from personal communication with Dudkina and Dudkina et al., 2006) 
  I+III2 III2+IV1-2 I+III2+IV1-4 V2 
Plants Arabidopsis O, X - - O 
 Barley X - - - 
 Bean X - - - 
 Potato O, X O, X O, X O, X 
 Spinach X X X X 
 Tobacco X - - - 
 Pea X - - - 
 Sunflower - X - - 
 Maize O - - O 
 Asparagus X - - X Algae Chlamydomonas - - - X 
 Polytomella O, X - - O, X Fungi S. cerevisiae - O, X - O, X 
 Yarrowia lipolytica X X X X 
 Podospora anserina X - X X Protists Tetrahymena O - - O 
Animals Bovine O, X X O, X O, X 
 Homo sapiens X - X - 
 
While the existence of supercomplexes is now well established, their function is 
not as well defined (Blaza et al., 2014; Genova and Lenaz, 2014). The prevailing view is 
that supercomplex formation offers a kinetic advantage by increasing the efficiency of 
electron transfer through spatial restriction of electron carrier diffusion, a process known 
as substrate channeling (Acin-Perez et al., 2008). The structure of the Bovine I1III2IV1 
supercomplex revealed potential pathways that could be used to channel electrons 
between these three complexes, providing evidence that supports substrate channeling 
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(Althoff et al., 2011). However, a similar study by Dudkina et al. doubted whether a 13 
nm gap between the Coenzyme Q binding sites of complex I and complex III would 
support substrate channeling (2011). Furthermore, additional work concluded that 
supercomplexes do not have a dedicated Q pool and do not trap cytochrome c, 
suggesting supercomplexes do not play a substantial kinetic role in catalysis (Blaza et 
al., 2014; Trouillard et al., 2011). Alternatively, Blaza et al. proposed that 
supercomplexes form out of spatial necessity, as the inner mitochondrial membrane has 
to maintain an extremely high protein concentration while avoiding nucleation and 
aggregation (2014). Although the functional significance of supercomplex formation is 
still murky, it is well established that the disruption in the function of MRC 
supercomplexes perturbs mitochondrial bioenergetics, and that the loss of supercomplex 
formation is associated with a rare genetic disorder called Barth syndrome (McKenzie et 
al., 2006). Notably, perturbations in MRC function have been associated with many 
common disorders including diabetes (Szendroedi et al., 2012), cancer (Hanahan and 
Weinberg, 2011; Wallace, 2012), neurodegenerative disorders (Nunnari and 
Suomalainen, 2012), cardiovascular diseases (Huss and Kelly, 2005) as well as rare 
inborn errors of metabolism (Vafai and Mootha, 2012; Koopman et al., 2012). 
Interestingly, significant amounts of phospholipids were found bound to purified 
supercomplexes (Althoff et al., 2011), suggesting that phospholipids play a vital role in 
supercomplex biogenesis. The specific phospholipid requirement for MRC 
supercomplex formation is discussed further in Chapter II of this dissertation. 
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Supercomplex formation has also been suggested to play a role in reducing 
oxidative stress, a relationship that has been examined in a variety of model systems 
(Maranzana et al., 2013; Lenaz et al., 2010; Baracca et al., 2010; Strogolova et al., 2012; 
Chen et al., 2008). These studies support a link between supercomplex disassociation 
and enhanced reactive oxygen species (ROS) production. Specifically, Maranzana et al. 
suggested that ROS produced by complex I is reduced when this complex is 
incorporated into supercomplexes (2013). However, a recent review notes that many 
functional studies investigating the relationship between supercomplex formation and 
ROS generation fail to distinguish causality (Genova and Lenaz, 2014). A better 
understanding of the requirement for supercomplex formation in mediating oxidative 
stress will shed light on the molecular basis underlying the mitochondrial pathogenesis 
associated with the loss of supercomplex formation (Schlame, 2013) 
MRC Function and Mitochondrial Membrane Phospholipid Composition 
The lipid matrix of biological membranes determines generic physical properties, 
such as membrane surface charge, thickness, fluidity, and curvature (de Kroon et al., 
2013). Each membrane is a complex assembly of different lipid molecules, with a lipid 
composition tailored to the function of the particular membrane (de Kroon et al., 2013). 
Mitochondrial membranes consist predominantly of phospholipids, which make up 75-
95% of total mitochondrial membrane lipids in yeast and higher eukaryotes (Horvath 
and Daum, 2013). Mitochondrial membranes mainly comprise three types of 
phospholipids, including phosphatidylcholine (PC), phosphatidylethanolamine (PE), and 
cardiolipin (CL), along with the less abundant phosphatidylinositol (PI), 
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phosphatidylserine (PS), and phosphatidic acid (PA). These phospholipids can be further 
categorized, based on their overall shape, as bilayer or non-bilayer forming 
phospholipids. According to the shape-structure concept of lipid polymorphism, bilayer-
forming phospholipids, like PC, are cylindrical in shape and can self assemble into a 
phase similar to a biological membrane (Fig. 1.2). Whereas, non-bilayer phospholipids, 
like PE and CL, are cone-shaped and promote membrane curvature when introduced into 
biological membranes (Fig 1.2) (Holthuis and Menon, 2014). As our understanding of 
membrane biology deepens, it is becoming clear that these phospholipids are more than 
just membrane building blocks. Non-bilayer forming phospholipids have been shown to 
influence the function of both peripheral (Li et al., 2003; Attard et al., 2000) and integral 
(van der Does et al., 2000; Botelho et al., 2002; Schwarz et al., 1997) membrane 
proteins. The non-bilayer phospholipids may mediate their effects through direct protein-
lipid interaction or by alterations in bulk properties, such as membrane surface charge, 
thickness, fluidity, and curvature (van Meer et al., 2008).  
Figure 1.2 The shape-structure concept of phospholipid polymorphism.  
PE is cone-shaped non-bilayer forming phospholipid that promotes membrane curvature, 
whereas PC is cylindrical in shape that forms membrane bilayers. 
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The biological significance of bilayer and non-bilayer forming phospholipids was 
eluded to by early studies showing that their ratio is tightly regulated (Morein et al., 
1996), and that they are essential for cell viability (Rietveld et al., 1993). As far as 
mitochondrial phospholipid composition is concerned, the ratio of non-bilayer to bilayer 
forming phospholipids is highly conserved (Fig 1.3A) (Daum, 1985), suggesting their 
importance in mitochondrial membrane structure and function. When compared to other 
cellular membranes, the curved inner mitochondrial membrane is enriched in non-bilayer 
forming phospholipids (Fig. 1.3B) (Zinser et al., 1991), suggesting these cone-shaped 
phospholipids play an important role in the function of the proteins embedded in this 
membrane. Together, PC, PE and CL comprise 80-90% of total mitochondrial 
phospholipids in yeast and humans, respectively (Horvath and Daum, 2013). However, 
the specific contribution of these phospholipids versus their contribution to bulk 
membrane properties in MRC function and formation is not well defined. Determining 
how alterations in the non-bilayer to bilayer ratio affect MRC function and formation as 
well as the ability of similarly shaped phospholipids to compensate for one another will 
further our understanding of the relationship between the MRC and its phospholipid 
membrane environment.  
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Figure 1.3 Mitochondrial membrane phospholipid composition is highly conserved. 
(A) Pie charts depicting the distribution of mitochondrial membrane phospholipids in eukaryotes 
(Data from Daum, 1985). (B) Proportion of non-bilayer forming phospholipids in different 
organellar membrane fractions (Data from Zinser et al., 1992). 
Phospholipid Synthesis 
 Phospholipid biosynthetic pathways are well conserved from yeast to humans, 
and these pathways are compartmentalized into various subcellular organelles, including 
the endoplasmic reticulum (ER), endosome, and mitochondria. Only the non-bilayer 
phospholipids PE and CL are synthesized within the mitochondria, suggesting these 
phospholipids are important for mitochondrial function (Gohil and Greenberg, 2009). 
CL is exclusively synthesized in the mitochondria from its precursor PA, which must be 
imported from the ER. Once imported, PA is converted to phosphatidylglycerol (PG) by 
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the sequential action of the mitochondrial Pgs1 and Gep4 enzymes. A diacylglycerol 
moiety is further added to PG via cytidinediphospho-diacylglycerol (CDP-DAG) by CL 
synthase, or Crd1, to form premature CL. The acyl chain composition of newly formed 
CL species is remodeled by the sequential action of a cardiolipin-specific deacylase, 
Cld1, and a transacylase, Taz1, to generate mature CL. Unlike CL, which is exclusively 
synthesized within the mitochondria, PE can be synthesized both inside and outside of 
the mitochondria. Within the mitochondrial inner membrane, PE is synthesized by 
decarboxylation of PS via phosphatidylserine decarboxylase, or Psd1. Psd1 accounts for 
80% of PS decarbolxylase activity in yeast and is the primary source of cellular PE. A 
second PS decarboxylase, Psd2, is a yeast specific enzyme that is localized to an 
endosomal compartment (Gulshan et al., 2010). PE synthesized by Psd2 is mainly used 
as a substrate for PC (Bürgermeister et al. 2004a). The de novo biosynthesis of PC 
proceeds through three sequential methylations of PE catalyzed by two ER-localized 
phosphatidylethanolamine methyltransferases, Pem1 and Pem2. In addition to the de 
novo biosynthetic pathways, PE and PC can be synthesized from their precursors 
ethanolamine (Etn) or choline (Cho), respectively, through the non-mitochondrial 
Kennedy pathway (Kennedy and Weiss, 1956). The Kennedy pathway consists of three 
enzymatic steps. First Etn or Cho is phosphorylated by ethanolamine kinase (Eki1) or 
choline kinase (Cki1), respectively. The second step is considered the rate-limiting step 
of this pathway and is catalyzed by ethanolamine-phosphate cytidylyltransferase (Ect1) 
or phosphocholine cytidylyltransferase (Pct1). These enzymes utilize 
phosphoethanolamine or phosphocholine and cytidine-5-triphosphate (CTP) to form the 
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high-energy intermediate CDP-ethanolamine or CDP-choline, respectively. Finally, 
ethanolamine phosphotransferase (Ept1) and choline phosphotransferase (Cpt1) form PE 
and PC, respectively, by incorporation of the lipid anchor diacylglycerol (DAG). 
Interestingly, the Kennedy pathway and de novo synthesis produce unique phospholipid 
species defined by the composition of their acyl chains (Bleijerveld et al., 2007; 
Boumann et al., 2003). However, the significance of this phenomenon in not well 
understood. The contribution of these pathways to cellular phospholipid composition 
differs among organisms and is influenced by growth conditions. In yeast, the Etn-
Kennedy pathway is only essential in the absence of the PS decarboxylase enzymes, and 
its activity can be regulated by the composition of the growth media (Birner et al., 2001). 
Disruption of the Kennedy pathway in mammals is embryonic lethal or results in severe 
deformities (Vance and Vance, 2009), and the contribution of the Kennedy pathway to 
cellular PE content is tissue specific (Gibellini and Smith, 2010). Because disruptions in 
phospholipid homeostasis are associated with several human diseases (Lu and Claypool 
2015), understanding the relative contribution of the phospholipid biosynthetic pathways 
will play a crucial role in understanding the mechanism of disease pathogenesis as well 
as in devising potential therapeutic approaches for these newly emerging disorders for 
which no therapies currently exists. 
Phospholipid Transport 
As discussed in the previous section, phospholipid biosynthesis is 
compartmentalized in different subcellular organelles from where they are transported to 
other subcellular membranes. Our current understanding of phospholipid transport is 
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limited, especially when compared to protein transport (Tamura et al., 2014; Scharwey et 
al., 2013). However, recent studies have begun to provide intriguing insights into 
phospholipid exchange between the ER and mitochondria as well as between the 
mitochondrial outer and inner membranes (Kornmann et al., 2009; Elbaz-Alon et al., 
2014; Aaltonen et al., 2016; Connerth et al., 2012). These studies have proposed two 
distinct mechanisms of phospholipid transport. One model is based on the close 
apposition of donor and recipient membranes and the other involves a phospholipid-
binding transport protein. One of the major unanswered questions in mitochondrial 
membrane biogenesis is how the phospholipid substrates PS and PA are transported to 
mitochondria. Most of the mitochondrial PE requirement is met by PE synthesized 
within, therefore whether non-mitochondrial PE, synthesized by Psd2 or by the Kennedy 
pathway, can be imported into mitochondria remains controversial (Bürgermeister et al., 
2004a; Chan and McQuibban, 2012; Wang et al., 2014). Results from Bürgermeister et 
al. are consistent with equilibrium transport of PE and PC between mitochondrial and 
microsomal membranes (Bürgermeister et al., 2004a; Bürgermeister et al., 2004b). 
However, subsequent studies showed that PE synthesized by the Kennedy pathway is not 
able to restore mitochondrial respiration (Chan and McQuibban, 2012; Wang et al., 
2014) implying that either PE transport from ER to mitochondria is insufficient to 
functionally compensate for a lack of mitochondrial PE biosynthesis or that the non-
mitochondrial PE species cannot substitute for mitochondrial PE species. By elucidating 
the mechanisms underlying phospholipid transport we can design approaches to 
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manipulate mitochondrial membrane composition to control mitochondrial function. 
Mitochondrial PE import is further described in Chapter II of this dissertation. 
Cardiolipin 
CL is a unique dimeric phospholipid that is almost exclusively located in 
membranes that house energy-transducing machinery, including the bacterial plasma 
membrane and the mitochondrial inner membrane. Therefore, its role in MRC function 
and formation has been examined more extensively than other more abundant 
mitochondrial phospholipids, like PE and PC. Within the inner mitochondrial membrane, 
CL is required for the optimal activities of complex I (Fry and Green, 1981; Paradies et 
al., 2002; Drose et al., 2002), complex III (Fry and Green, 1981; Gomez Jr and 
Robinson, 1999; Lange et al., 2001), complex IV (Robinson, 1993), and complex V 
(Eble et al., 1990). Furthermore, the crystal structures of complex III (Lange et al., 2001) 
and complex IV (Ozawa et al., 1982) revealed tightly bound CL molecules in conserved 
binding sites, suggesting CL as an integral component of these complexes. Respiratory 
supercomplexes containing complex III and complex IV are destabilized in mitochondria 
lacking CL (Pfeiffer et al., 2003; Zhang et al., 2002). Specifically, CL is thought to 
neutralize a positively charged region of complex III that allows for interaction with 
complex IV and stabilizes supercomplex formation (Wenz et al., 2009). The requirement 
for CL in supercomplex formation was further elucidated when CL was found to be 
absolutely required for the in vitro reconstitution of the yeast tetrameric supercomplex, 
III2IV2 (Bazan et al., 2013). However, it is not clear if the in vivo requirement of CL in 
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supercomplex formation is specific or if any perturbations in membrane phospholipid 
composition disrupt supercomplex formation. 
In addition to the MRC, CL interacts with several different transporter proteins. 
For example, the activity of the essential ADP/ATP carrier (AAC) protein also requires 
CL (Jiang et al., 2000, Claypool, 2009). Moreover, CL associates with and is required 
for the activity of carrier proteins for phosphate (Kadenbach et al., 1982), pyruvate 
(Nalecz et al., 1986), carnitine (Indiveri et al., 1991), and adenine nucleotides (Beyer and 
Klingenberg, 1985). In addition, its interaction with cytochrome c has implicated CL in 
the process of apoptosis (Petrosillo et al., 2001; Gonzalvez and Gottlieb, 2007; 
Huttemann et al., 2011). The peroxidation of CL bound to cytochrome c is an essential 
step in its release during apoptosis (Kagan et al., 2005). CL contains a high proportion of 
unsaturated acyl chains, which are particularly susceptible to ROS-induced oxidation 
(Paradies et al., 2014). Interestingly, exogenously added CL-liposomes prevented ROS 
mediated inactivation of MRC complexes while PE, PC, and oxidized CL were unable to 
prevent this effect (Paradies et al., 2001; Paradies et al., 2000). Due to its multiple roles, 
disruptions in CL biosynthesis have a broad impact on mitochondrial function and 
cellular physiology. 
Barth Syndrome 
The importance of CL in mitochondrial function is underscored by the fact that 
genetic mutation of a CL remodeling enzyme TAZ leads to the debilitating disorder 
known as Barth syndrome (BTHS) (Bione et al., 1996; Schlame and Ren, 2006). BTHS 
is an X-linked genetic disorder characterized by cardiomyopathy, skeletal muscle 
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myopathy, neutropenia, growth-delay, and exercise intolerance (Barth et al., 1983). 
Studies from BTHS patient cells - as well as a number of model systems, including the 
yeast Saccharomyces cerevisiae - have shown that mitochondrial dysfunction caused by 
perturbation of mitochondrial membrane phospholipid composition is the primary cause 
of BTHS pathology (Vreken et al., 2000; Schlame et al., 2003; Gu et al., 2004). 
Specifically, BTHS mitochondria contain elevated monolysocardiolipin (MLCL), no 
tetralinoleoyl-CL, and an overall decrease in CL levels. The downstream consequences 
of the altered mitochondrial phospholipid composition in BTHS cells are the 
destabilization of the MRC supercomplexes and increased oxidative stress (McKenzie et 
al., 2006). Similarly, the destabilization of MRC supercomplexes and increased 
oxidative stress were observed in a yeast model of BTHS (Brandner et al., 2005; Chen et 
al., 2008). Interestingly, these phenotypes are not observed in yeast cells where MLCL 
accumulation is prevented. These results suggest MLCL build-up is the major 
contributor to mitochondrial dysfunction, not alterations in CL species or overall levels 
(Ye et al., 2014; Baile et al., 2014; Tyurina et al., 2017). These recent findings highlight 
the potential for targeting mitochondrial membrane phospholipid composition in 
correcting the pathophysiology associated with BTHS. 
Phosphatidylethanolamine and Phosphatidylcholine 
Mitochondrial PE is critically important during the development of a 
multicellular organism, as indicated by the study showing that the elimination of the 
mitochondrial PE biosynthetic enzyme PISD1/Psd1 in mice is embryonic lethal 
(Steenbergen et al., 2005). PE is not just a membrane constituent, it is essential for 
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protein biogenesis (Becker et al., 2013), folding (Bogdanov and Dowhan 1998; 
Bogdanov and Dowhan, 1999), and function (Bogdanov and Dowhan, 1995) as well as a 
variety of important cellular processes, including autophagy (Ichimura et al., 2000), 
membrane fusion (Verkleij et al., 1984), and mitochondrial function (Birner et al., 2001; 
Storey et al., 2001). Two groups have recently examined the role of PE in mitochondrial 
bioenergetics, but the results from their studies have painted a conflicting picture. In a 
study performed on Chinese hamster ovary cells, in which Pisd activity is reduced by 
62%, a variety of mitochondrial defects, including aberrant mitochondrial morphology, 
reduced respiration, increased mitochondrial membrane potential, reduced level and 
activity of complex IV, and destabilization of complex IV-containing supercomplexes 
(Tasseva et al., 2013) were observed. However, these results are in direct contrast to a 
recent study in yeast psd1Δ cells, where mitochondrial membrane potential was reduced 
and a higher order complex IV-containing supercomplex was observed (Bottinger et al., 
2012). The conflicting phenotypes observed in these studies could be due to use of 
different model systems or different growth conditions. Even within the same model 
system, it has been long known that phospholipid composition is influenced by the 
growth conditions (Storey et al., 2001; Gohil et al., 2005). For example, the reduction in 
respiratory growth of psd1Δ cells is much more pronounced in synthetic lactate medium 
devoid of Etn (Birner et al., 2001) when compared to complex lactate medium (Bottinger 
et al., 2012), which presumably contains enough Etn to drive PE synthesis by Kennedy 
pathway (Storey et al., 2001). Therefore, the question remains: Does mitochondrial PE 
play a specific role in MRC function and formation? Chapter II of this dissertation 
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addresses this question by characterizing MRC function in yeast mutants where PE is 
depleted.   
PE also serves as the phospholipid substrate for PC, which constitutes 40-50% of 
phospholipids in most organelles (Vance, 2015). The prevailing view is that PC simply 
serves as a membrane building block (Choi et al., 2004). However, this idea overlooks 
earlier studies showing that PC functions as storage for arachidonoyl fatty acids (Kramer 
and Deykin, 1983; Ziboh and Lord, 1979). Recent work has revealed different PC 
species that function as protein ligands and influence gene expression (Kersten, 2014; 
Lee et al., 2011). In addition, PC may play a role in insulin signaling (Ersoy et al., 2013; 
Sakai et al., 2014). Interestingly, PC depleted mice, lacking the PE methyltransferase 
enzyme, were protected against diet-induced obesity and insulin resistance (Jacobs et al., 
2010). Mitochondria from these mice revealed increased activities of cytochrome c 
oxidase and succinate reductase. Accordingly, ATP levels in hepatocytes from PC 
depleted mice were double that of control mice (van der Veen et al., 2014). In addition to 
increased mitochondrial respiration, this study noted a strong correlation between an 
increased mitochondrial PE-to-PC ratio and increased cellular ATP levels in PC depleted 
hepatoma cells (van der Veen et al., 2014). Despite these recent advances, the precise 
role of PC in MRC function and formation has not been examined. It is not well 
understood how cells tolerate a loss in what normally comprises ~50% of mitochondrial 
membrane phospholipids, but a study in yeast suggests that upon PC depletion, the fatty 
acid chains of PE are remodeled rendering a more bilayer-like phospholipid species that 
can compensate for the loss of PC (Boumann et al., 2006). These findings raise the 
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following questions: Do disruptions in PC biosynthesis result in a loss of the absolute 
amount of phospholipids or simply alterations in phospholipid ratios, without decreasing 
total phospholipid content? How does the loss of the most abundant mitochondrial 
phospholipid affect MRC function and formation? Chapter II of this dissertation 
addresses these questions by characterizing MRC function in a yeast mutant where PC is 
depleted. 
Overlapping Functions of Mitochondrial PE and CL 
Owing to their similar biophysical properties, PE and CL have been proposed to 
have overlapping functions. For example, the simultaneous loss of mitochondrial PE and 
CL biosynthetic enzymes leads to synthetic lethality (Gohil et al., 2005; Osman et al., 
2009). Several studies have implicated the involvement of CL and PE in the 
maintenance of mitochondrial morphology (Osman et al., 2009; Kuroda et al., 2011). 
Furthermore, both PE and CL are required for mitochondrial fusion, protein import, and 
MRC activities (Jiang et al., 2000; Bottinger et al., 2012; Joshi et al., 2012; Becker et al., 
2013). In an Escherichia coli strain lacking PE, there is a three to five fold elevation of 
CL (Rietveld et al., 1993). Conversely, the disruption of CL biosynthesis in yeast results 
in increased mitochondrial PE (Zhong et al., 2004; Tuller et al., 1998), suggesting a 
compensatory mechanism in which the loss of one non-bilayer forming phospholipid is 
compensated by an increase in the other. Based on these observations, I have examined 
the ability of elevated mitochondrial PE to compensate for CL deficiency in BTHS yeast 
cells in Chapter III of this dissertation. 
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Yeast as a Model System  
Since phospholipid biosynthetic pathways are essential in mammals, it has been 
difficult to definitively dissect their precise role in MRC function. Therefore, the 
genetically tractable model organism Saccharomyces cerevisiae, where phospholipid 
biosynthetic mutants are viable, is ideal to dissect the role phospholipids play in MRC 
structure and function. In addition, the yeast lipidome only contains a few-hundred lipid 
species (Guan and Wenk, 2006; Ejsing et al., 2009), whereas mammalian cells have 
thousands (Sampaio et al., 2011; Yetukuri et al., 2008). The simplicity of the yeast 
lipidome simplifies the task of studying lipid homeostasis. Furthermore, unlike 
mammalian cells that require serum for growth, yeast can be cultured in media with 
defined compositions. This is especially important because phospholipid composition is 
influenced by growth conditions (Storey et al., 2001; Gohil et al., 2005; Santos and 
Riezman, 2012). Notably, the average concentration of Etn in the serum of an adult 
human is ~2 µM (Kume et al., 2006), which could affect PE levels. Both yeast and 
mammalian cells can take up molecules that influence phospholipid synthesis and 
composition. These include small phospholipid precursors like Etn, Cho, and inositol, as 
well as free fatty acids and lyso-phospholipids (Santos and Riezman, 2012). These 
molecules are abundant in serum or yeast extract containing media, therefore the 
phenotypic interpretation of phospholipid mutants becomes difficult when cells are 
cultivated in lipid-rich conditions. A primary example of this is the different phenotypes 
observed when PE mutants are grown in rich versus synthetic growth media (Birner et 
al., 2001; Chan and McQuibban, 2012). In yeast extract containing, rich media it is much 
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more difficult to elevate mitochondrial PE through Etn supplementation, presumably 
because the presence of choline in rich media reduces levels of the Etn importer, Hnm1 
(Fernández-Murray et al., 2013). Importantly, all the experiments in this dissertation 
were performed in synthetic defined medium to reproducibly control phospholipid 
levels. 
S. cerevisiae also serves as an excellent model organism for studying 
mitochondrial biology. Yeast can survive on a fermentable carbon source, like glucose, 
in the absence of mitochondrial respiration. This allows for the identification of genes 
required for mitochondrial function through a simple comparison of growth in 
fermentable media with that in non-fermentable media. Mutants of essential 
mitochondrial genes that are not viable in higher organisms can be characterized in yeast 
because of this ability to produce sufficient energy via glycolysis in glucose-containing 
medium. Finally, the high conservation of the mitochondrial proteome and 
phospholipids between yeast and humans make yeast ideal for dissecting fundamental 
mitochondrial processes, as well as furthering our understanding of mitochondrial 
diseases. 
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CHAPTER II  
SPECIFIC REQUIREMENTS OF NON-BILAYER PHOSPHOLIPIDS IN 
MITOCHONDRIAL RESPIRATORY CHAIN FUNCTION AND FORMATION* 
Disclaimer 
 Chapter II is a reprint of a publication for which I am the first author. In this 
chapter, I describe my work utilizing yeast phospholipid mutant strains to define the 
function of the three most abundant mitochondrial phospholipids in MRC activity and 
assembly. The summary section of this chapter is the abstract of the publication, and the 
rest is as published. I performed all the experimental work described in this chapter 
except for the transmission electron micrographs (Fig. 2.3) and the respiration 
measurements (Fig. 2.5C and D), which were performed by Erin N. Pryce and Dr. 
Writoban Basu Ball. I also greatly appreciate Dr. Writoban Basu Ball’s help in 
performing mitochondrial isolation and phospholipid measurements (Fig. 2.2). 
* Republished with permission of Molecular Biology of the Cell, from Special
Requirements of Nonbilayer Phospholipids in Mitochondrial Respiratory Chain Function and Formation, 
Baker CD, Basu Ball W, Pryce EN, Gohil VM, 27(14) 2016; Permission conveyed through Copyright 
Clearance Center, Inc. 
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Summary 
 Mitochondrial membrane phospholipid composition impacts mitochondrial 
function by influencing the assembly of the mitochondrial respiratory chain (MRC) 
complexes into supercomplexes. For example, the loss of cardiolipin (CL), a signature 
non-bilayer forming phospholipid of mitochondria, results in disruption of MRC 
supercomplexes. However, the functions of the most abundant mitochondrial 
phospholipids, bilayer-forming phosphatidylcholine (PC) and non-bilayer forming 
phosphatidylethanolamine (PE) are not clearly defined. Using yeast mutants of PE and 
PC biosynthetic pathways, we show a specific requirement for mitochondrial PE in 
MRC complex III and IV activities but not for their formation, whereas loss of PC does 
not affect MRC function or formation. Unlike CL, mitochondrial PE or PC are not 
required for MRC supercomplex formation emphasizing the specific requirement of CL 
in supercomplex assembly. Interestingly, PE biosynthesized in the endoplasmic 
reticulum (ER) can functionally substitute for the lack of mitochondrial PE biosynthesis, 
suggesting the existence of PE transport pathway from ER to mitochondria. To 
understand the mechanism of PE transport, we disrupted ER-mitochondrial contact sites 
formed by the ERMES complex and show that, though not essential for PE transport, 
ERMES facilitates the efficient rescue of mitochondrial PE deficiency. Our work 
highlights specific roles of non-bilayer-forming phospholipids in MRC function and 
formation.  
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Introduction 
The mitochondrial respiratory chain (MRC) consists of four multimeric protein 
complexes (complex I-IV) that generate an electrochemical proton gradient across the 
mitochondrial inner membrane driving adenosine triphosphate (ATP) synthesis via ATP 
synthase (complex V). MRC complexes are embedded within the inner mitochondrial 
membrane, where they interact in different stoichiometries and assemble into supra-
molecular structures known as supercomplexes (Dudkina et al., 2011; Schagger and 
Pfeiffer, 2000). Supercomplex formation increases the efficiency of electron transfer by 
spatial restriction of electron carrier diffusion (Acín-Pérez et al., 2008). Disruption in the 
function or formation of MRC complexes or supercomplexes perturbs mitochondrial 
bioenergetics manifesting clinically in a wide range of metabolic disorders (Koopman et 
al., 2012; Nunnari and Suomalainen, 2012; Vafai and Mootha, 2012). Thus, 
manipulating the function of the MRC complexes has been proposed as a possible 
therapeutic avenue for the treatment and prevention of these diseases (Walters et al., 
2012; Weinberg and Chandel, 2015).  
Traditionally, the functions of MRC complexes have been studied in isolation 
from their native membrane environment, often overlooking the contribution of 
membrane lipids (Gohil and Greenberg, 2009). Phospholipids constitute a large 
proportion of mitochondrial membrane lipid milieu where they specify MRC function by 
influencing physical properties of the membrane and by specific phospholipid:protein 
interactions (Horvath and Daum, 2013; Ren et al., 2014). Mitochondrial membranes 
contain all of the major classes of phospholipids found in cell membranes, including 
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phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), 
phosphatidylserine (PS), and phosphatidic acid (PA), as well as cardiolipin (CL), which 
is predominantly, if not exclusively, found in the mitochondria (Horvath and Daum, 
2013). PC is the most abundant mitochondrial phospholipid, accounting for almost 50% 
of total phospholipids (Horvath and Daum, 2013). The cylindrical shape of PC promotes 
bilayer formation. PE is the second most abundant mitochondrial phospholipid and has a 
cone-shape structure that imposes negative curvature stress on the membrane, increasing 
its tendency to form non-bilayer structures (Holthuis and Menon, 2014). Like PE, CL is 
the other major cone-shaped mitochondrial phospholipid with the tendency to induce 
negative membrane curvature to the lipid bilayer. These ‘non-bilayer’ forming 
phospholipids are proposed to facilitate membrane fusion and influence the binding and 
activity of membrane proteins (van Meer et al., 2008). The ratio of bilayer to non-
bilayer-forming phospholipids in the mitochondria is roughly equal and highly 
conserved suggesting both coordinate regulation of their biosynthesis and their 
importance in mitochondrial function (Daum, 1985).  
Phospholipid biosynthesis in eukaryotes is compartmentalized into various 
subcellular organelles, including the endoplasmic reticulum (ER), endosome, and 
mitochondria. Mitochondria are able to synthesize PE and CL in situ, whereas all the 
other phospholipids are imported (Gohil and Greenberg, 2009) (Fig. 2.1). CL is 
synthesized from phosphatidylglycerol (PG) and cytidinediphospho-diacylglycerol 
(CDP-DAG) in the inner mitochondrial membrane, by CL synthase, Crd1. The acyl 
chain composition of newly formed CL species is remodeled by the sequential action of 
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cardiolipin-specific deacylase, Cld1, and a transacylase, Taz1, to generate mature CL. 
PE is synthesized by decarboxylation of PS via phosphatidylserine decarboxylase 1, 
Psd1, which is localized to the inner mitochondrial membrane and is the primary source 
of cellular PE (Bürgermeister et al., 2004a). The yeast specific enzyme Psd2 is localized 
to an endosomal compartment (Gulshan et al., 2010) and contributes to the cellular PE 
content to a lesser extent (Bürgermeister et al., 2004a). The de novo biosynthesis of PC 
proceeds through three sequential methylations of PE catalyzed by 
phosphatidylethanolamine methyltransferases, Pem1 and Pem2. In addition to these de 
novo biosynthetic pathways, PE and PC can be synthesized from their precursors 
ethanolamine (Etn) or choline (Cho), respectively, through the non-mitochondrial 
Kennedy pathway (Fig. 2.1). Currently, the functional contribution of the Kennedy 
pathway phospholipids to mitochondrial membranes is not clear. Results from 
Bürgermeister et al. are consistent with equilibrium transport of PE and PC between 
mitochondrial and microsomal membranes (Bürgermeister et al., 2004a; Bürgermeister 
et al., 2004b). However, subsequent studies showed that PE synthesized by the Kennedy 
pathway is not able to restore mitochondrial respiration (Chan and McQuibban, 2012; 
Wang et al., 2014) implying that either PE transport from ER to mitochondria is 
insufficient to functionally compensate for the lack of mitochondrial PE biosynthesis or 
that the non-mitochondrial PE species cannot substitute for mitochondrial PE species.  
Although the role of CL in MRC function and formation has been extensively 
studied (Joshi et al., 2009; Mileykovskaya and Dowhan, 2014), the roles of more 
abundant mitochondrial phospholipids including PE and PC are incompletely 
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understood. Recently, depletion of mitochondrial PE in mammalian cells was shown to 
result in reduced respiratory capacity, ATP production and destabilization of complex 
IV-containing supercomplexes (Tasseva et al., 2013). In contrast, yeast cells lacking 
mitochondrial PE biosynthesis was shown to contain higher order supercomplexes 
(Bottinger et al., 2012). While these studies suggest conflicting roles of PE in MRC 
assembly, the role of PC in mitochondrial bioenergetics has not been investigated at all. 
Therefore, it is not clear whether MRC defects are exclusive to alterations in non-bilayer 
mitochondrial phospholipids, like PE and CL, or simply the result of any perturbation in 
mitochondrial phospholipid composition.  
Figure 2.1 Aminoglycerophospholipids and CL biosynthetic pathways in yeast. 
PE biosynthesis in yeast is accomplished by three major pathways: 1) Psd1-catalyzed 
decarboxylation of PS in the mitochondria, 2) Psd2-catalyzed decarboxylation of PS in 
endosomal compartments, and 3) incorporation of Etn via the cytosolic/ER Kennedy pathway. 
PC is produced by two major pathways: 1) formation of Pem1 and Pem2 PC by successive 
methylation of PE, and 2) incorporation of choline via the Kennedy pathway. CL biosynthesis 
occurs exclusively in the mitochondria, where premature cardiolipin (CLp) is synthesized from 
phosphatidylglycerol (PG) by Crd1. The resulting CLp is deacylated by the phospholipase Cld1 
to produce monolysocardiolipin (MLCL) and reacylated by Taz1 to form mature cardiolipin 
(CLm). CDP, cytidine diphosphate; CTP, cytidine triphosphate; CMP, cytidine monophosphate; 
DAG, diacylglycerol; PA, phosphatidic acid; PI, phosphatidylinositol; PDME, 
phosphatidyldimethylethanolamine; PPi, inorganic pyrophosphate. 
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To address these gaps in our knowledge, in this report, we have used isogenic 
yeast mutants of PE and PC biosynthetic enzymes to systematically dissect their roles in 
MRC biogenesis. We show that the disruption of mitochondrial PE biosynthesis causes 
diminished activities of fully assembled MRC complex III and IV containing 
supercomplexes. Surprisingly, the most abundant mitochondrial phospholipid, PC, is not 
required for MRC function or formation. In contrast to the prevailing model of inter-
organelle phospholipid trafficking (Lahiri et. al, 2015; Osman et al., 2011), we 
demonstrate that PE synthesized in the ER via the Kennedy pathway can be transported 
into mitochondria, where it can fully substitute for the loss of mitochondrial PE 
biosynthesis. Our work thus, identifies specific roles of the two most abundant 
mitochondrial phospholipids in MRC biogenesis and provides means for manipulating 
mitochondrial phospholipid composition by stimulating non-mitochondrial Kennedy 
pathway.   
Results 
Deletion of Psd1 and Pem2 Dramatically Alters Mitochondrial PE/PC Ratio  
In order to dissect the roles of the two most abundant mitochondrial 
phospholipids, PE and PC, in MRC function and formation in vivo, we focused on 
psd1Δ and pem2Δ cells, which lack key enzymes for PE and PC biosynthesis, 
respectively (Fig. 2.1). Previous studies have shown that phospholipid composition and 
mitochondrial biogenesis is dependent upon carbon source used in the growth medium 
(Tuller et al., 1999). Therefore, we analyzed the phospholipid composition of yeast cells 
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grown in glucose-containing fermentable (SC glucose) or lactate-containing non-
fermentable (SC lactate) carbon sources. Whole cell phospholipid analysis of glucose-
grown psd1Δ cells revealed a three-fold reduction in PE with a concomitant increase in 
PC (Fig. 2.2A). Conversely, pem2Δ cells showed a 15-fold reduction in PC with a two-
fold increase in PE and its precursor, phosphatidylmonomethylethanolamine (PMME), 
which could not be separated by the thin layer chromatography used in this study (Fig. 
2.2A). Similar PE and PC changes were observed when psd1Δ and pem2Δ cells were 
grown in a medium containing lactate (Fig. 2.2B). To analyze mitochondrial 
phospholipid composition, we obtained highly purified mitochondria with minimal 
contamination from other cellular organelles (Fig. 2.2C). Consistent with whole cell 
phospholipid composition, the levels of PE decreased by ~six-fold in psd1Δ 
mitochondria (Fig. 2.2D). The decrease in PE in psd1Δ mitochondria was accompanied 
by alterations in other phospholipids, including a significant increase in PC and PA and a 
decrease in CL (Fig. 2.2D). In pem2Δ mitochondria, PC levels decreased by five-fold 
while the PE/PMME content doubled (Fig. 2.2D). We also observed a significant 
accumulation of phosphatidyldimethylethanolamine (PDME) in pem2Δ mitochondria 
(Fig. 2.2D). In both glucose and lactate-containing media, the absolute phospholipid 
levels in whole cells and in isolated mitochondria did not change in either mutant 
relative to the wild type (WT) cells (Fig. 2.2E-G). These results suggest that in yeast 
cells a homeostatic mechanism exists which buffers cells against the loss of the absolute 
amount of membrane phospholipids, such that the depletion in PE is compensated by an 
increase in PC, and vice-versa. Therefore, psd1Δ and pem2Δ cells have a significantly 
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altered PE/PC ratio, without any change in their absolute amount of membrane 
phospholipids. We noted that the mitochondrial PE/PC ratio in WT was 0.503, which 
was reduced to 0.065 in psd1Δ cells and increased to 6.02 in pem2Δ cells. Despite these 
dramatic deviations in the mitochondrial PE/PC ratios in psd1Δ and pem2Δ cells, the 
gross cellular and mitochondrial morphology remained unaltered, with only a small 
reduction in the average length of mitochondrial cristae and outer membrane in psd1Δ 
cells (Fig. 2.3B). There was no change in mitochondrial cristae length of pem2Δ cells, 
but we did observe a slight reduction in the average outer membrane length (Fig. 2.3C). 
Collectively, these results demonstrate that yeast cells can tolerate extensive alteration in 
mitochondrial PE/PC ratios and that a decrease in the PE level is countered by an 
increase in PC, and vice-versa.  
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Figure 2.2 Cellular and mitochondrial phospholipid composition of psd1Δ and pem2Δ cells. 
The whole-cell phospholipid composition of WT, psd1Δ, and pem2Δ cells grown in (A) SC 
glucose and (B) SC lactate. Phospholipid levels are expressed as the percentage of total 
phospholipid phosphorus in each phospholipid class. PE# represents the sum of PE and PMME 
in pem2Δ cells. Data are expressed as mean ± SD (n = 3); **p < 0.005, *p < 0.05. (C) Western 
blot analysis of crude and sucrose-gradient purified mitochondria from WT cells. Cox2, Dpm1, 
Pho8, and Pgk1 are used as markers of the yeast mitochondria, ER, vacuole, and cytoplasm, 
respectively. (D) Phospholipid composition of sucrose gradient–purified mitochondria from WT, 
psd1Δ, and pem2Δ cells grown in SC lactate. Data are expressed as mean ± SD (n = 3); **p < 
0.005, *p < 0.05. (E, F) Total phospholipid content of whole-cell homogenates of WT, psd1Δ, 
and pem2Δ cells grown in (E) SC glucose or (F) SC lactate. (G) Total phospholipid content of 
mitochondria from SC lactate-grown cells. Data are expressed as mean ± SD (n = 3). 
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Figure 2.3 Cellular and mitochondrial morphology of PE and PC depleted cells. 
(A) Representative transmission electron micrographs from the total of 20 different images of 
WT, (B) psd1Δ, and (C) pem2Δ cells are shown. Top panel shows yeast cells and bottom panel 
shows mitochondria (scale bars, 1 µm). Arrows in top panel indicate mitochondria shown in 
bottom panel. (D) Box plots depicting the average number of mitochondria per cell, (E) average 
cristae length per mitochondrion, and (F) average outer mitochondrial membrane (OM) length. 
Box plots shown in (D), (E), and (F) show median, first and third quartiles, greatest values 
within 1.5 inter-quartile range, and outliers, *p < 0.05 and **p < 0.005. 
Decreased Mitochondrial PE/PC Ratio Results in Reduced Respiration and ATP Levels  
To dissect the specific roles of PC and PE in MRC function, we performed 
extensive growth characterization of psd1Δ and pem2Δ cells in different carbon sources. 
The growth of psd1Δ and pem2Δ cells in fermentable SC glucose medium was 
comparable to WT cells (Fig. 2.4A and 2.5A). Consistent with a previous report (Birner 
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et al., 2001), the growth of psd1Δ cells in non-fermentable SC lactate medium was 
severely compromised, whereas pem2Δ cells were able to grow albeit with slightly 
reduced rate (Fig. 2.4B and 2.5B). The growth defects in non-fermentable medium 
suggested respiratory deficiency.  
Figure 2.4 Growth of PE and PC depleted cells in liquid media. 
(A) Growth of WT, psd1Δ, and pem2Δ cells in SC glucose or (B) SC lactate liquid medium at 
30°C was monitored by measuring absorbance at 600 nm. Data are representative of at least 
three independent measurements. 
To directly assess respiration, we measured oxygen consumption in WT, psd1Δ, 
and pem2Δ cells. Consistent with the severely diminished respiratory growth, the psd1Δ 
cells had a ~60% reduction in oxygen consumption compared to WT cells (Fig. 2.5C and 
D). Oxygen consumption in pem2Δ cells was comparable to WT cells in SC lactate and 
even slightly elevated in SC glucose media (Fig. 2.5C and D). The reduced growth of 
pem2Δ cells could be due to defects in mitochondrial protein import machinery as 
reported recently (Schuler et al., 2015) and not due to defects in respiration per se. In 
accordance with reduced respiration in psd1Δ cells, we observed a significant 50% 
reduction in ATP levels, while the ATP levels in the respiratory competent pem2Δ cells 
remained unaltered (Fig. 2.5E and F). These results suggest that mitochondrial PE, but 
not PC, is essential for maintaining normal respiration.  
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Figure 2.5 Mitochondrial respiration is dependent on PE but not PC levels. 
Tenfold serial dilutions of WT, psd1Δ, and pem2Δ cells were spotted onto (A) SC glucose and 
(B) SC lactate plates, and images were captured after 2 (SC glucose) or 5 d (SC lactate) of 
growth at 30°C. Data are representative of at least three independent experiments. (C, D) WT, 
psd1Δ, and pem2Δ cells were grown in (C) SC glucose or (D) SC lactate to late log phase, and 
the rate of oxygen consumption was measured. Data are expressed as mean ± SD (n = 6); *p < 
0.05, **p < 0.005. (E, F) Cellular ATP levels of WT, psd1Δ, and pem2Δ cells cultured in (E) SC 
glucose or (F) SC lactate. Data are expressed as mean ± SD (n = 3); *p < 0.05. 
Decreased Mitochondrial PE/PC Ratio Reduces MRC Supercomplex Activities without 
Affecting Supercomplex Formation  
To ascertain the biochemical basis for reduced respiration in PE depleted cells, 
we analyzed the levels of native and denatured MRC complexes in the mitochondrial 
lysate from WT, psd1Δ and pem2Δ cells grown in SC lactate medium. There was no 
change in the steady-state levels of individual MRC subunits (Fig. 2.6) or their 
incorporation into fully assembled MRC complexes in either of the mutant cells (Fig. 
2.7A and B). As reported previously, MRC supercomplexes containing complex III and 
IV were disrupted in CL-lacking crd1Δ cells (Zhang et al., 2002; Pfeiffer et al., 2003). 
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These results imply that reduced PE and accompanying 33% decrease in CL levels in 
psd1Δ is insufficient to disrupt supercomplex formation. We noticed that pem2Δ cells, 
which exhibit an increased PE/PC ratio, showed an enhanced formation of a larger 
supercomplex (III2IV2) at the expense of the smaller supercomplex (III2IV) (Fig. 2.7A). 
The lack of alterations in the amount and assembly of the MRC complexes cannot 
explain the respiratory deficiency of psd1Δ cells, suggesting that the reduced respiration 
could be due to a decrease in MRC activity. Therefore, we measured the enzymatic 
activities of MRC complexes and observed a four-fold and a two-and-half-fold 
reductions in complex III and complex IV activities, respectively, in psd1Δ cells (Fig. 
2.7C and D). The specific reduction in complex III and complex IV activities could, in 
part, explain the respiratory defects observed in psd1Δ cells. The activities of MRC 
complexes were comparable in WT and pem2Δ cells (Fig. 2.7C and D), which is 
consistent with the normal respiratory phenotype of pem2Δ cells. Together, these results 
demonstrate specific requirement of CL for MRC supercomplex formation and PE for 
MRC complex III and IV activities, whereas PC is redundant for these functions.  
Figure 2.6 Steady-state levels of MRC subunits are unaltered in PE and PC depleted cells. 
Mitochondria from SC lactate grown WT, psd1Δ, and pem2Δ cells were subjected to SDS-PAGE 
and immunoblotted using complex II, III, IV, and V specific antibodies Sdh2, Rip1, Cox2, and 
Atp2, respectively. Porin was used as a loading control. Data are representative of at least three 
independent experiments. 
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Figure 2.7 Mitochondrial PE is required for MRC complex III and IV activities but not 
MRC supercomplex formation. 
(A) Mitochondria from SC lactate–grown cells were solubilized by 1% digitonin and subjected 
to BN–PAGE/Western blot, and complexes II–V were detected by Sdh2, Rip1, Cox2, and Atp2 
antibodies, respectively. Mitochondria from CL-deficient crd1Δ cells were used as positive 
control to demonstrate loss of supercomplexes (III2IV2, large supercomplex; III2IV, small 
supercomplex) under identical conditions. (B) Samples from A were stained with Coomassie 
blue to demonstrate equal loading. (C) Digitonin-solubilized mitochondrial complexes from WT, 
psd1Δ, and pem2Δ cells were separated by CN-PAGE, followed by in-gel activity staining for 
complexes II–V. In-gel activities of MRC complexes were quantified by densitometric analysis, 
and relative activities were plotted for complexes II–V. Data were normalized to WT cells and 
expressed as mean ± SD (n = 3); **p < 0.005. (D) Samples from C were stained with Coomassie 
blue, and total protein, quantified using densitometric analysis, was used to normalize activity 
staining. 
Depletion of PE Results in a Specific Loss of Mitochondrial DNA-Encoded MRC 
Subunits  
In contrast to previous studies (Tasseva et al., 2013; Bottinger et al., 2012), 
which reported aberrant formation of MRC supercomplexes in PE depleted cells, we did 
not find any alterations in the MRC supercomplexes in psd1Δ cells. We reasoned that 
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this discrepancy could be related to use of different growth conditions and carbon 
sources in these studies. Indeed, we found reduced levels of MRC supercomplexes 
(III2IV2 and III2IV) in glucose grown psd1Δ cells (Fig. 2.8A). These carbon source-
dependent differences in MRC supercomplex assembly might be due to increased petite 
formation in psd1Δ cells as reported previously (Birner et al., 2001). The petite 
phenotype results from mutations in the mitochondrial genome or loss of mitochondrial 
DNA (mtDNA), which leads to the loss of mtDNA-encoded MRC subunits. Consistent 
with the previous report, we found a significant increase in the number of petite colonies 
in the psd1Δ mutant (Fig. 2.9). Accordingly, SDS-PAGE/western blot analysis of MRC 
subunits showed a specific decrease in the steady-state levels of mtDNA-encoded 
subunits Cox1, Cox2, and Cox3 (Fig. 2.8B) without affecting the levels of the nuclear-
encoded subunits Sdh2, Rip1, Cox4, and Atp2 (Fig. 2.8C). Unlike PE depleted psd1Δ 
cells, loss of PC in pem2Δ cells did not result in any alterations in the assembly or 
steady-state levels of MRC complexes or petite formation (Figs. 2.8 and 2.9). 
Collectively, these results suggest that the decrease in the MRC supercomplex levels in 
glucose-grown psd1Δ cells results from the loss of mtDNA-encoded subunits. 
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Figure 2.8 Depletion of mitochondrial PE in glucose-grown psd1Δ cells results in a specific 
loss of mtDNA-encoded MRC subunits. 
(A) Digitonin-solubilized mitochondria from SC glucose–grown WT, psd1Δ, and pem2Δ cells 
were subjected to BN–PAGE/Western blot. Complexes II–V were detected by Sdh2, Rip1, 
Cox2, and Atp2 antibodies, respectively. Data are representative of at least three independent 
experiments. (B) Mitochondria from SC glucose–grown WT, psd1Δ, and pem2Δ cells were 
subjected to SDS–PAGE, and mtDNA-encoded subunits were probed using Cox1, Cox2, and 
Cox3 antibodies. (C) Nuclear-encoded subunits were probed using Sdh2, Rip1, Cox4, and Atp2. 
Porin was used as a loading control. Data are representative of at least three independent 
experiments. 
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Figure 2.9 Depletion of mitochondrial PE in glucose grown psd1Δ cells results in enhanced 
petite formation. 
Respiratory deficient petite cells from SC glucose grown WT, psd1Δ, and pem2Δ cells were 
quantified by counting colonies in fermentable and non-fermentable media. Data are expressed 
as mean ± S.D. (n=3), *p < 0.05. 
PE Synthesized via Kennedy Pathway Completely Rescues Respiratory Defects of 
psd1Δ Cells by Restoring Mitochondrial PE Levels  
In order to determine if PE synthesized in ER by the CDP-Etn branch of the 
Kennedy pathway could compensate for the loss of mitochondrial PE, we grew psd1Δ 
cells in the presence of Etn and measured cellular and mitochondrial phospholipids. Etn 
supplementation in psd1Δ cells completely restored cellular PE and significantly restored 
mitochondrial PE levels (Fig. 2.10A and B). Interestingly, supplementation of Etn not 
only rescued mitochondrial PE levels but also restored PA and CL levels in psd1Δ 
mitochondria (Fig. 2.10B), implying that a yet unidentified homeostatic mechanism 
regulates the precise proportion of individual phospholipids in mitochondrial 
membranes. Next, we asked whether the partial restoration of mitochondrial PE through 
exogenous Etn supplementation could restore the respiratory defects observed in psd1Δ 
cells. Indeed, Etn supplementation rescued the respiratory growth defect of psd1Δ cells 
in SC lactate medium (Fig. 2.10C and D). Consistent with the rescue of respiratory 
growth, Etn supplementation restored oxygen consumption (Fig. 2.10E) and cellular 
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ATP content (Fig. 2.10F) in psd1Δ cells to WT levels. In order to investigate the 
mechanism by which Etn rescued respiration, we measured MRC complex III and IV 
activities and found that their activities were restored to WT levels in Etn supplemented 
psd1Δ cells (Fig. 2.10G and H). Etn supplementation not only restored respiratory 
function in SC lactate, but also rescued petite formation and cellular ATP levels in SC 
glucose medium (Fig. 2.11). Taken together, these results show that PE synthesized in 
ER by the Kennedy pathway can replenish mitochondrial PE and restore MRC complex 
III and IV activities in psd1Δ cells.  
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Figure 2.10 Ethanolamine supplementation rescues respiratory defects of psd1Δ cells by 
restoring mitochondrial PE levels. 
(A) Cellular and (B) mitochondrial phospholipid composition of WT cells grown in SC lactate 
and psd1Δ cells grown in SC lactate with and without 2 mM Etn. Phospholipid levels are 
expressed as percentage of total phospholipid phosphorus in each phospholipid class. Data are 
expressed as mean ± SD (n = 3); **p < 0.005, *p < 0.05. Tenfold serial dilutions of WT and 
psd1Δ cells were spotted onto (C) SC lactate and (D) SC lactate + 2 mM Etn plates, and images 
were captured after 4 days of growth at 30°C. Data are representative of at least three 
independent trials. (E) Rate of oxygen consumption and (F) total cellular ATP levels of WT and 
psd1Δ cells grown in SC lactate ± 2 mM Etn to late logarithmic phase were quantified. Data are 
expressed as mean ± SD (n = 3); *p < 0.05, **p < 0.005 (G, H) Digitonin solubilized 
mitochondrial complexes from WT and psd1Δ cells grown in SC lactate ± 2 mM Etn were 
separated by CN-PAGE, followed by in-gel activity staining for (G) complex III and (H) 
complex IV. Densitometric quantifications of relative in-gel activities for complexes III and IV. 
Data were normalized to WT cells and are expressed as mean ± SD (n = 3); **p < 0.005, *p < 
0.05. A.U., arbitrary units. 
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Figure 2.11 Ethanolamine supplementation reduces petite formation and restores cellular 
ATP levels in PE depleted cells. 
(A) WT cells were grown in SC glucose and psd1Δ cells were grown in SC glucose ± 2 mM 
ethanolamine (Etn) for 16 hours. The percentage of petite colonies in these cultures was 
calculated by dividing the number of viable colonies in non-fermentable (YPlac) medium with 
the number of viable colonies in fermentable (YPD) medium. Data are expressed as mean ± S.D. 
(n=3) *p < 0.05. (B) Total cellular ATP levels of WT and psd1Δ cells cultured in SC glucose ± 2 
mM Etn. Data are expressed as mean ± S.D. (n=3) *p < 0.05. 
ERMES Facilitates Etn Dependent Rescue of Mitochondrial PE Deficiency  
The complete rescue of mitochondrial bioenergetic phenotypes and respiratory 
growth of psd1Δ cells by Etn supplementation implies efficient transport of PE from ER 
to mitochondria (Fig. 2.12A). To understand the molecular basis of PE import to 
mitochondria, we focused on ERMES complex, a mitochondria-ER tethering structure 
proposed to be involved in trafficking phospholipids between ER and mitochondria 
(Kornmann et al., 2009). First, to rule out the possibility that Etn itself or one of its 
metabolite is responsible for the psd1Δ rescue, we deleted the Kennedy pathway enzyme 
Ect1 in psd1Δ cells and show that the rescue of psd1Δ cells by Etn is completely 
abrogated (Fig. 2.12B). This result clearly demonstrates that PE synthesized via the 
Kennedy pathway is essential for psd1Δ rescue. Next, we deleted two ERMES subunits, 
Mdm34 or Mdm12, both of which contain the synaptotagmin-like mitochondrial lipid 
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binding protein domain (SMP) (AhYoung et al., 2015), in psd1Δ cells and found that Etn 
rescue is reduced in the double mutants (Fig. 2.12C and D). To reveal the involvement 
of the ERMES complex in PE transport, we measured the phospholipid levels in 
mitochondria of psd1Δmdm34Δ cells with and without Etn supplementation. We did not 
observe any significant decrease in the steady levels of mitochondrial PE in the double 
mutant as compared to psd1Δ single mutant after Etn supplementation (Fig. 2.13). These 
results suggest that ERMES is not essential for the import of non-mitochondrial PE to 
mitochondria but may only indirectly facilitate Etn-mediated rescue of psd1Δ cells.  
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Figure 2.12 PE synthesized by the Kennedy pathway requires ERMES for complete rescue 
of mitochondrial PE deficiency. 
(A) Schematic representation of the Kennedy pathway of PE biosynthesis and the ERMES 
complex. The Kennedy pathway enzyme Ect1, mitochondrial Psd1, and Mdm34 and Mdm12 of 
the ERMES complex are depicted in boldface to indicate that these genes are targeted to 
construct double-knockout strains. Tenfold serial dilutions of (B) WT, ect1Δ, psd1Δ, and 
psd1Δect1Δ, (C) WT, psd1Δ, mdm34Δ, and psd1Δmdm34Δ, and (D) WT, psd1Δ, mdm12Δ, and 
psd1Δmdm12Δ cells were spotted onto SC glucose and SC lactate ± Etn plates, and images were 
captured after 2 (SC glucose) or 5 d (SC lactate ± Etn) of growth at 30°C. Data are representative 
of at least three independent experiments. 
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Figure 2.13 Mitochondrial phospholipid composition of indicated yeast mutants. 
Mitochondrial phospholipids of WT cells grown in SC lactate and psd1Δ or psd1Δmdm34Δ cells 
grown in SC lactate with and without 2 mM ethanolamine (Etn). Phospholipid levels are 
expressed as the percentage of total phospholipid phosphorus in each phospholipid class. Data 
are expressed as mean ± S.D. (n=3). Mitochondrial phospholipid levels in WT and psd1Δ cells 
are from Figure 2.2. 
Discussion 
Perturbations in mitochondrial membrane phospholipid composition have been 
shown to cause MRC dysfunction (Lu and Claypool, 2015; Chicco and Sparagna, 2007). 
Therefore, delineating the specific roles of the individual phospholipids of mitochondrial 
membranes is critical in understanding MRC function. In this study, we used yeast 
mutants of PE and PC biosynthetic pathways to show a specific requirement of 
mitochondrial PE for MRC complex III and IV activities, whereas loss of PC was well 
tolerated. Furthermore, we show that PE synthesized in the ER via Kennedy pathway 
can be efficiently transported to the mitochondrial membranes, where it can completely 
substitute for the lack of mitochondrial PE biosynthesis. Our results suggest a specific 
requirement of non-bilayer promoting phospholipids, PE and CL, in MRC function and 
formation.  
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Analysis of the phospholipid profiles of psd1Δ and pem2Δ cells revealed a 
cellular homeostatic mechanism that maintained absolute phospholipid concentrations. 
For example, depletion of PE is always accompanied by an increase in the level of PC, 
and vice versa (Fig. 2.2A, B, and D). As a result, the mutants harboring PSD1 or PEM2 
deletions had altered PE/PC ratios rather than a change in the absolute amount of one 
particular phospholipid (Fig. 2.2E-G). Therefore, it is important to interpret results in 
terms of alterations in relative levels of different classes of phospholipids rather than a 
single phospholipid. Currently, we do not know the molecular basis for homeostatic 
mechanisms that strictly maintain total cellular and mitochondrial phospholipid levels. 
We predict that such homeostatic mechanisms are likely mediated by feedback inhibition 
of phospholipid biosynthetic enzymes and cross-pathway regulations by phospholipid 
precursors, a prediction supported by previous studies (Carman and Han, 2011). Apart 
from the overall mitochondrial membrane phospholipid content, MRC assembly and 
activity has been linked to cristae shape (Cogliati et al., 2013). Therefore, we analyzed 
mitochondrial morphology of psd1Δ and pem2Δ mutants by transmission electron 
microscopy and found that the gross mitochondrial structure and overall cristae 
morphology remain unaffected in PE and PC deficient mitochondria (Fig. 2.3) with only 
a small reduction in the average mitochondrial cristae length in psd1Δ mutants (Fig. 
2.3E).  
Earlier studies focused on defining the role of PE in mitochondrial functions 
have been performed in different growth media, resulting in conflicting phenotypes 
(Birner et al., 2001; Chan and McQuibban, 2012). This is not surprising since it has been 
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long known that phospholipid composition is influenced by the growth conditions of 
yeast cells (Storey et al., 2001; Gohil et al., 2005). For example, the reduction in 
respiratory growth of psd1Δ cells is much more pronounced in synthetic lactate medium 
devoid of Etn (Birner et al., 2001) when compared to complex lactate media (Bottinger 
et al., 2012), which presumably contains enough Etn to drive PE synthesis by Kennedy 
pathway (Storey et al., 2001). Therefore, in the present study, all the experiments were 
performed in the synthetic defined medium to reproducibly control phospholipid levels. 
The psd1Δ cells cultured in synthetic medium showed a dramatic decrease in the 
mitochondrial PE/PC ratio (Fig. 2.2D), which reduced MRC function (Fig. 2.5). These 
bioenergetic deficits could be partly attributed to the reduced activities of the MRC 
complexes III and IV (Fig. 2.7C). Decreased ATP and respiration in psd1Δ cells could 
also be due to the reduced mitochondrial membrane potential and protein import, as has 
been previously described (Bottinger et al., 2012). Thus, our findings on the role of PE 
in mitochondrial bioenergetics are partly consistent with previous studies in yeast 
(Bottinger et al., 2012) and mammalian cell lines (Tasseva et al., 2013), but unlike these 
reports, we did not find any perturbations in MRC supercomplexes in PE-depleted 
mitochondria (Fig. 2.7A). This discrepancy could be due to use of different growth 
conditions. Indeed, we observed reduced levels of MRC supercomplexes in psd1Δ cells 
cultured in glucose-containing medium (Fig. 2.8A). Thus, our results obtained from 
isogenic yeast mutants grown under identical conditions clearly demonstrate that of the 
three most abundant mitochondrial phospholipids (PC, PE, and CL) only CL is essential 
for MRC supercomplex formation (Fig. 2.7A and B).  
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While previous studies have provided insights into the specific role of CL in 
MRC biogenesis (Wenz et al., 2009; Bazan et al., 2013), they did not address if the 
mitochondrial phospholipid requirement is specific for non-bilayer-forming 
phospholipids, or if any perturbation in phospholipid composition will result in MRC 
defects in vivo. We found that, unlike non-bilayer forming PE and CL, depletion in 
bilayer-forming PC did not alter mitochondrial bioenergetic parameters (Figs. 2.5-2.7). 
A five-fold depletion in mitochondrial PC had no effect on MRC function or formation, 
which is surprising, considering that PC constitutes almost half of all the mitochondrial 
membrane phospholipids. Three previous reports provide possible explanation to this 
observation. First, the loss of PC in yeast is accompanied by the remodeling of fatty acyl 
species of PE into more of a bilayer-forming phospholipid, thus maintaining the ratio of 
non-bilayer to bilayer-forming phospholipids (Boumann et al., 2006). Second, 90% of 
bacteria do not contain PC in the cellular membranes that harbor their oxidative 
phosphorylation machinery (Aktas et al., 2010). Third, elevation of non-bilayer 
phospholipids like PE and phosphatidylpropanolamine in PC lacking cells were able to 
support growth in non-fermentable medium, suggesting that bilayer-forming PC is not 
essential for respiratory growth of yeast S. cerevisiae (Choi et al., 2004). Collectively, 
these studies indicate that MRC activity or assembly is more resistant to perturbation in 
PC levels but is very sensitive to changes in non-bilayer phospholipids. Interestingly, we 
observed that depletion of PC with a concomitant increase in PE+PMME resulted in 
enhanced formation of the large supercomplex III2IV2 and free complex IV at the 
expense of the small supercomplex III2IV (Fig. 2.7A), suggesting that formation of MRC 
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supercomplexes can be modulated by altering the bulk properties of membranes in 
addition to specific molecular interactions with CL. Additionally, PC-depleted cells 
showed an increased rate of oxygen consumption (Fig. 2.5C), a finding consistent with a 
recent study in mammalian cells lacking a mammalian homolog of yeast Pem2 (van der 
Veen et al., 2014). Thus, our findings in yeast cells are likely applicable to mammalian 
cells.  
Next, we asked if PE synthesized in ER could be transported to mitochondria to 
compensate for the lack of mitochondrial PE biosynthesis. Previous reports paint a 
conflicting picture, one line of evidence shows that the reduced respiratory growth of 
psd1Δ cells is rescued by Etn supplementation (Birner et al., 2001; Riekhof and Voelker, 
2006), whereas other studies show that PE synthesized by the Kennedy pathway does 
not meet the requirements for respiration in psd1Δ cells (Chan and McQuibban, 2012; 
Wang et al., 2014). Here, we show that exogenous Etn supplementation not only restores 
cellular PE levels but also significantly increases mitochondrial PE levels in psd1Δ cells 
and fully rescues all mitochondrial bioenergetic defects observed in psd1Δ cells (Fig. 
2.10). These results imply that mitochondrial PE import pathway(s) exist and that non-
mitochondrial PE can functionally compensate for the lack of mitochondrial PE 
biosynthesis. The requirement of ERMES complex for the efficient rescue suggested that 
the membrane contact sites between ER and mitochondria may facilitate PE import into 
mitochondria. However, steady state levels of mitochondrial PE did not reduce upon Etn 
supplementation in psd1Δ cells lacking the ERMES complex (Fig. 2.13), implying that 
ERMES is not essential for PE transport but may only play an indirect role in Etn-
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mediated rescue (Fig. 2.12). In summary, as depicted in our model (Fig. 2.14), this work 
identified critical roles of non-bilayer phospholipids in MRC activity and assembly, 
respectively and showed that non-mitochondrial PE can be transported to mitochondria, 
where it can functionally substitute for PE deficiency.  
Figure 2.14 Model depicting the specific roles of mitochondrial PE and PC in MRC 
complex activity and assembly. 
Reduced PE/PC ratio in mitochondrial PE–depleted psd1Δ cells leads to decreased MRC 
complex III and IV activities without affecting supercomplex formation. The increased PE/PC 
ratio in mitochondrial PC-depleted pem2Δ cells results in enhanced formation of the larger 
supercomplex (III2IV2) without altering the activities of complexes. PE synthesized in ER by 
exogenous supplementation of Etn is transported into mitochondria and completely restores 
MRC supercomplex activities in PE-deficient psd1Δ cells. IMM, inner mitochondrial membrane; 
IMS, intermembrane space; OMM, outer mitochondrial membrane. 
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Materials and Methods 
Yeast Strains, Growth Medium Composition, and Culture Conditions  
Saccharomyces cerevisiae strains used in this study are listed in Table 2.1. For 
growth in liquid media, strains were pre-cultured in YPLac medium (1% yeast extract, 
2% peptone, and 2% lactate pH 5.5) and inoculated into SC media (0.2% dropout mix 
containing amino acid and other supplements as previously described (Amberg et al., 
2005), 0.17% yeast nitrogen base without amino acids and ammonium sulfate, and 0.5% 
ammonium sulfate) containing either 2% glucose or 2% lactate (pH 5.5) and grown to 
late logarithmic phase. Solid media were prepared by the addition of 2% agar. Liquid SC 
glucose and SC lactate was inoculated with WT or the indicated strains to a starting A600 
of 0.1 and growth was monitored for up to 30 h (SC glucose) or 60 h (SC lactate) at 
30°C. For growth on solid media, ten-fold serial dilutions of overnight pre-cultures were 
spotted on SC glucose or SC lactate plates and incubated at 30°C for 2 days (SC 
glucose) and 4-5 days (SC lactate) respectively. For Etn supplementation experiments, 2 
mM Etn was added to SC growth medium. Petite formation was determined by 
spreading glucose grown cells (200 cells/100 µL) onto YPD and YPlac plates. Petite 
formation was calculated based on the number of colonies that grew on YPD (total 
viable cells) compared to YPlac (respiratory competent) media. Single and double 
knockout yeast strains (Table 2.1) were constructed by one-step gene disruption using 
hygromycin cassette (Janke et al., 2004).  
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Table 2.1 Yeast strains used in this study 
Yeast Strains Genotype Source 
BY4741 WT MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 Greenberg, M.L. 
BY4741 psd1Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, psd1Δ::kanMX4 Open Biosystems 
BY4741 pem2Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, pem2Δ::kanMX4 Open Biosystems 
BY4741 crd1Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, crd1Δ::kanMX4 Open Biosystems 
BY4741 ect1Δ  MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, ect1Δ::hphNT1 This study 
BY4741 psd1Δ ect1Δ  MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, psd1Δ::kanMX4, ect1Δ::hphNT1 This study 
BY4741 mdm34Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, mdm34Δ::kanMX4 Open Biosystems 
BY4741 psd1Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, psd1Δ::hphNT1 This study 
BY4741 mdm12Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, mdm12Δ::kanMX4 Open Biosystems 
BY4741 mdm34Δ 
psd1Δ  
MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
mdm34Δ::kanMX4, psd1Δ::hphNT1 This study 
BY4741 mdm12Δ 
psd1Δ  
MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
mdm12Δ::kanMX4, psd1Δ::hphNT1 This study 
Mitochondrial Isolation  
Isolation of crude and pure mitochondria was performed as described previously 
(Meisinger et al., 2006). Mitochondria were isolated from yeast cells grown to late 
logarithmic phase and were subsequently used for western blot analysis as well as in-gel 
activity assays. For obtaining pure mitochondrial fractions, crude mitochondria were 
loaded onto a sucrose step gradient (60%, 32%, 23% and 15%) and centrifuged at 
134,000 g for 1 h. The intact mitochondria recovered from the gradient interface (60% 
and 32%) were washed in isotonic buffer, pelleted at 10,000 g, and subsequently used 
for mitochondrial phospholipid quantification. Protein concentrations were determined 
by the BCA assay (Thermo Scientific).  
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Cellular and Mitochondrial Phospholipid Measurements  
For the quantification of cellular and mitochondrial phospholipids, lipids were 
extracted from cells (1 g wet weight) or pure mitochondria (1.5 mg protein) using the 
Folch method (Folch et al., 1956), and individual phospholipids were separated by two-
dimensional thin layer chromatography using the following solvent systems: 
chloroform/methanol/ammonium hydroxide (65:35:5) in first dimension followed by 
chloroform/acetic acid/methanol/water (75:25:5:2.2) in second dimension (Storey et al., 
2001). Phospholipids were visualized with iodine vapor, scraped into glass tubes, and 
inorganic phosphate was quantified. The quantification of total cellular phospholipids 
was performed as previously described (Horvath et al., 2011). Briefly, 100 mg of SC 
glucose or SC lactate grown cells were digested with zymolyase, homogenized, and the 
cells debris were pelleted (3000 g, 5 min). Phospholipids were extracted from the cell 
free homogenate using the Folch method (Folch et al., 1956) and the total phospholipid 
phosphate was quantified using the Bartlett method (Bartlett, 1959). The mitochondrial 
phospholipid phosphate was extracted from 1.5 mg of pure mitochondria and was 
quantified using the Bartlett method (Bartlett, 1959).  
Electron Microscopy  
Yeast cells cultured in SC lactate medium were harvested and fixed in 3% 
glutaraldehyde contained in 0.1 M sodium cacodylate, pH 7.4, 5 mM CaCl2, 5 mM 
MgCl2, and 2.5% (w/v) sucrose for 1 h at room temperature with gentle agitation, 
spheroplasted, embedded in 2% ultra low temperature agarose (prepared in water), 
cooled, and subsequently cut into small pieces (~1 mm3). The cells were then post-fixed 
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in 1% OsO4 and 1% potassium ferrocyanide contained in 0.1 M sodium cacodylate for 1 
h at room temperature. The blocks were washed thoroughly three times with double 
distilled H2O, transferred to 1% thiocarbohydrazide at room temperature for 3 min, 
washed in double distilled H2O twice, and transferred to 1% OsO4 and 1% potassium 
ferrocyanide in 0.1 M sodium cacodylate, for an additional 3 min at room temperature. 
The cells were washed three times with double distilled H2O and stained in 
Kellenberger's uranyl acetate at room temperature overnight. Cells were then dehydrated 
through a graded series of cold ethanol followed by room temperature 100% ethanol 
exchanges, washed twice in propylene oxide, left overnight in propylene oxide/Epon 
with gentle agitation and subsequently embedded in Epon resin. Sections were cut on a 
Leica Ultracut UCT ultramicrotome, and observed on a Philips EM420 transmission 
electron microscope at 100 kV. Images were recorded with a Soft Imaging System 
Megaview III digital camera, and figures were assembled in Adobe Photoshop with only 
linear adjustments in contrast and brightness.  
Measurement of Oxygen Consumption and ATP Levels  
For measurements of respiration rates, cells were grown to late-log phase in SC 
glucose or SC lactate media, resuspended in fresh media at 108 cells/ml (SC glucose) or 
2x107 cells/ml (SC lactate), and the rate of oxygen consumption was measured at 30°C 
using Oxytherm (Hansatech). Cyanide-sensitive respiration was calculated after the 
addition of 1 mM KCN, and the cyanide-insensitive respiration was subtracted from the 
total respiration. For cellular ATP quantification, cells were seeded at 250,000 cells/well 
in a 96-well plate, and ATP was measured using the BacTiter-Glo Microbial Cell 
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Viability Assay (Promega) kit according to the manufacturer’s instructions. All data 
were normalized to the protein concentration, determined by the BCA assay (Thermo 
Scientific).  
Sodium Dodecylsulfate (SDS)- Blue Native (BN)- Polyacrylamide Gel Electrophoresis 
(PAGE) and Immunoblotting  
SDS-PAGE was performed on mitochondrial samples solubilized in lysis buffer 
(150 mM NaCl, 1 mM EDTA, 50 mM Tris–HCl, pH 7.4, 1% NP-40, 0.5% sodium 
deoxycholate and 0.1% SDS) supplemented with protease inhibitor cocktail (Roche 
Diagnostic). Protein extracts were separated on NuPAGE 4-12% Bis-Tris gels (Life-
Technologies), transferred on PVDF membranes using a Trans–Blot transfer cell (Bio-
Rad). Membranes were blocked in 5% fatty acid-free BSA dissolved in Tris–buffered 
saline with 0.1% Tween 20 and probed with antibodies as indicated. Blue native 
polyacrylamide gel electrophoresis (BN-PAGE) was performed to separate native MRC 
protein complexes as previously described (Wittig et al., 2006). Briefly, yeast 
mitochondria were solubilized in buffer containing 1% digitonin (Life-Technologies), 
and incubated for 15 min at 4°C. Following a clarifying spin at 20,000 × g (30 min, 
4°C), 50x G-250 sample additive was added to the supernatant and 20 µg of protein was 
loaded on a 3-12% gradient native PAGE Bis–Tris gel (Life-Technologies). Western 
blot was performed using a Mini-PROTEAN Tetra cell (Bio-rad). Membrane was 
blocked in 5% nonfat milk in Tris–buffered saline with 0.1% Tween 20 and probed with 
antibodies as indicated. Primary antibodies for yeast proteins used were: Cox1, 1:5,000 
(Abcam 110 270); Cox2, 1:50,000 (Abcam 110 271); Cox3, 1:5,000 (Abcam 110 259); 
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Cox4, 1:5,000 (Abcam 110 272): Sdh2, 1:5,000 (from Dr. Dennis Winge); Rip1, 
1:100,000 (from Dr. Vincenzo Zara); Atp2, 1:40,000 (from Dr. Sharon Ackerman); 
Porin, 1:50,000 (Abcam 110 326); Dpm1, 1:250 (Abcam 113 686); Pho8, 1:250 (Abcam 
113 688); Pgk1, 1:5,000 (Abcam 113 687). Secondary antibodies (1:5,000) were 
incubated for 1 h at room temperature, and membranes were developed using Western 
Lightning Plus-ECL (PerkinElmer).  
In-gel Activity Measurements  
In-gel activities for mitochondrial respiratory chain complexes were performed 
as described previously (Wittig et al., 2007). Clear Native Polyacrylamide Gel 
Electrophoresis (CN-PAGE) was used to avoid interference of Coomassie blue with 
activity measurements. Briefly, mitochondria solubilized in 1% digitonin were resolved 
on a 4-16% gradient native PAGE BisTris gel (Life-Technologies) using the following 
additions to the cathode buffer: for complex II, 0.01% n-Dodecyl β-D-maltoside (DDM) 
and 0.05% sodium deoxycholate (DOC) were added, for complex III there was no 
addition, for complex IV, 0.05% DDM and 0.05% DOC were added, and for complex V, 
0.01% DDM and 0.05% DOC were added. Gels were loaded with 30 µg of protein for 
complex II, 90 µg of protein for complex III and IV, and 20 µg of protein for complex V, 
and incubated in activity staining solutions for complex II, III, IV, or V as reported 
previously (Wittig et al., 2007). Band intensity quantification was done using the gel 
analysis method in ImageJ. Equal loading was determined by Coomassie blue stain, and 
total protein and band intensity quantification was done using the gel analysis method in 
ImageJ.  
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CHAPTER III  
ETHANOLAMINE ALLEVIATES OXIDATIVE STRESS AND MITOCHONDRIAL 
SUPERCOMPLEX ASSEMBLY DEFECTS IN CARDIOLIPIN DEFICIENT CELLS 
Disclaimer  
 I did all the experiments described in this chapter except for the ones reported 
in Fig. 3.2, 3.3, 3.5, 3.6, 3.8, 3.14, and 3.15, which were performed by Dr. Writoban 
Basu Ball, John K. Neff, and Gabriel L. Apfel. 
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Summary 
 Barth syndrome (BTHS) is a severely debilitating genetic disorder characterized 
by perturbations in mitochondrial phospholipid composition derived from a primary 
defect in cardiolipin (CL) biosynthesis. CL, like phosphatidylethanolamine (PE), is a 
non-bilayer forming phospholipid that is synthesized in the mitochondria. Due to their 
similar biophysical properties, PE and CL have been proposed to have overlapping 
functions, raising an intriguing possibility that elevating mitochondrial PE levels may 
compensate for CL deficiency in BTHS mitochondria. To test this hypothesis, we used 
an ethanolamine (Etn) supplementation strategy to elevate mitochondrial PE, and 
demonstrated that Etn supplementation rescues the respiratory growth of CL deficient 
cells. Surprisingly, Etn-mediated rescue was independent of PE biosynthesis and was 
solely dependent on soluble phospholipid precursors Etn and propanolamine, but not 
choline. Etn rescued respiratory growth by restoring respiratory chain supercomplex 
assembly and reducing oxidative stress in CL deficient taz1Δ cells, a yeast model of 
BTHS. Although Etn partially rescued the respiratory growth defect of crd1Δ cells, 
which are completely devoid of CL, it failed to rescue supercomplex formation, 
suggesting that supercomplex formation in vivo requires a critical amount of CL. Etn-
mediated rescue was specific to CL deficiency because Etn supplementation did not 
rescue respiratory defects caused by the loss of mitochondrial supercomplex assembly 
factors. Taken together, our work highlights a new role of Etn in attenuating 
mitochondrial dysfunction caused by CL deficiency. 
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Introduction 
Barth syndrome (BTHS) is a severely debilitating X-linked genetic disorder 
characterized by cardiomyopathy, skeletal muscle myopathy, neutropenia, growth-delay, 
and exercise intolerance (Barth et al., 1983). BTHS is caused by loss-of-function 
mutations in the evolutionarily conserved tafazzin (TAZ) gene (Bione et al., 1996). TAZ 
encodes a mitochondrial transacylase that remodels cardiolipin (CL), a signature 
phospholipid of mitochondrial membranes (Xu et al., 2003; Xu et al., 2006). Studies 
from BTHS patient cells - as well as a number of model systems, including the yeast 
Saccharomyces cerevisiae - have shown that mitochondrial dysfunction caused by 
perturbation of mitochondrial membrane phospholipid composition is the primary cause 
of BTHS pathology (Vreken et al., 2000; Schlame et al., 2003; Gu et al., 2004). 
Specifically, a decrease in remodeled CL species and an increase in monolysocardiolipin 
(MLCL) levels have been identified as the main factors that lead to altered mitochondrial 
structure and function (Ye et al., 2014; Baile et al., 2014). 
Apart from alterations in CL, perturbations in levels of other abundant 
mitochondrial phospholipids, including phosphatidylethanolamine (PE), have been 
observed in BTHS model organisms. For example, phospholipid analysis of yeast taz1Δ 
cells showed a significant increase in PE (Gu et al., 2004). Similarly, phospholipid 
analyses of cardiac tissue from children with BTHS showed a small increase in total PE, 
but almost a six-fold increase in C18:0-C18:2 species (Schlame et al., 2003; Valianpour 
et al., 2005). The downstream consequences of this altered mitochondrial phospholipid 
composition include the destabilization of the mitochondrial respiratory chain (MRC) 
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supercomplexes and increased oxidative stress (Brandner et al., 2005; McKenzie et al., 
2006; Jiang et al., 2000; Chen et al., 2008). 
PE and CL are both cone-shaped phospholipids with a tendency to form non-
bilayer structures in membranes (Holthuis and Menon, 2014). The non-bilayer forming 
phospholipids are proposed to facilitate membrane fusion and influence the binding and 
activity of membrane proteins (van den Brink-van der Laan et al., 2004). Unlike the 
bilayer-forming phospholipids phosphatidylcholine (PC) and phosphatidylserine (PS), 
mitochondrial PE and CL are synthesized in situ from their precursors PS and 
phosphatidic acid (PA), respectively, which are imported from the endoplasmic 
reticulum (Fig. 3.1). In addition to the mitochondrial pathway that involves the 
decarboxylation of PS by Psd1, PE can be synthesized either by a non-mitochondrial 
ethanolamine-Kennedy pathway or by a lyso-PE requiring pathway (Fig. 3.1). Compared 
to other subcellular organelles, the mitochondrial inner membrane is highly enriched 
with PE and CL, which constitute up to half of the total phospholipids (Zinser et al., 
1991). This suggests that these non-bilayer phospholipids have an important role in the 
structural organization of membranes harboring the MRC complexes. Indeed, previous 
studies using yeast crd1Δ cells that are deficient in CL biosynthesis have identified a 
specific role of CL in the MRC supercomplex formation (Zhang et al., 2002; Pfeiffer et 
al., 2003). Loss of CL is also accompanied by compromised mitochondrial bioenergetics 
(Jiang et al., 2000; Koshkin et al., 2000; Koshkin et al., 2002). More recently, it was 
shown that the loss of PE reduces MRC function in both yeast and mammalian cells due 
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to diminished MRC complex III and IV activities (Bottinger et al., 2012; Tasseva et al., 
2013; Baker et al., 2016).  
Figure 3.1 Biochemical pathways for PE, PC, and CL biosynthesis in the yeast 
Saccharomyces cerevisiae.  
CL biosynthesis occurs exclusively in the mitochondria, where Crd1 synthesizes nascent CLp 
from PG. The resulting CLp is deacylated by the phospholipase Cld1 to produce 
monolysocardiolipin (MLCL), which is then reacylated by the transacylase Taz1 to form mature 
cardiolipin (CLm). Mutations in the human homolog of TAZ1 result in Barth Syndrome. CL 
biosynthesis is dependent on the import of PA from endoplasmic reticulum (ER), which is 
converted to CDP-DAG by Cds1. Pgs1 catalyzes conversion of CDP-DAG to PGP, which is then 
dephosphorylated to PG by Gep4. PE biosynthesis in yeast occurs by three major pathways: (1) 
Psd1-catalyzed decarboxylation of PS in the mitochondria, (2) incorporation of Etn via the 
cytosolic/ER Kennedy pathway enzymes Eki1, Ect1, and Ept1, respectively, and (3) the 
acylation of lyso-PE by Ale1. The Kennedy pathway enzymes Cki1, Pct1, and Cpt1 can utilize 
choline to biosynthesize PC, a bilayerforming phospholipid that must be imported into 
mitochondria. CLp, precursor cardiolipin; CLm, mature cardiolipin; MLCL, monolysocardiolipin; 
PG, phosphatidylglycerol; PGP, phosphatidylglycerol phosphate; CDP, cytidine diphosphate; 
DAG, diacylglycerol; PA, phosphatidic acid; PS, phosphatidylserine; PE, 
phosphatidylethanolamine; PC, phosphatidylcholine. 
 
Owing to their similar shape, site of biosynthesis, and propensity to form non-
bilayer structures, PE and CL have been proposed to have overlapping functions (Gohil 
et al., 2005, Gohil and Greenberg 2009). For example, the simultaneous loss of 
mitochondrial PE and CL biosynthetic enzymes leads to synthetic lethality (Gohil et al., 
Figure 1
PE
PS
PG
CLp
MLCL
CLm
Etn CDP-EtnPhospho-Etn PEEct1 Ept1Eki1
Psd1
Crd1
Cld1
Taz1
Cho CDP-ChoPhospho-Cho PCPct1 Cpt1Cki1
Lyso-PE Ale1 PELyso-PE
Plasma
Membrane
Lyso-PE
Ethanolamine
(Etn)
Choline
(Cho)
PS
Pgs1
Cds1
PGP
PA PA CDP-DAG
Gep4
SerineSerineSerine Cho1
PC
Endoplasmic
ReticulumCytosol Mitochondria
  61 
2005; Osman et al., 2009). Furthermore, both PE and CL are required for mitochondrial 
fusion (Joshi et al., 2012), protein import (Becker et al., 2013) and MRC activities (Jiang 
et al., 2000; Bottinger et al., 2012). In an Escherichia coli strain lacking PE, there is a 
three to five fold elevation of CL (Rietveld et al., 1993). Similarly, the disruption of CL 
biosynthesis in yeast results in increased mitochondrial PE (Zhong et al., 2004; Tuller et 
al., 1998), suggesting a compensatory mechanism in which the loss of one non-bilayer 
forming phospholipid is compensated by an increase in the levels of another. Together, 
these findings led us to hypothesize that MRC defects due to disruptions in CL 
biosynthesis may be rescued by increasing mitochondrial PE levels.  
We recently showed that ethanolamine (Etn) supplementation increases 
mitochondrial PE levels in yeast (Baker et al., 2016), providing us with means to test our 
hypothesis. In the present study, we used an Etn-supplementation strategy in 
combination with yeast models of CL deficiency to demonstrate that Etn can rescue the 
respiratory growth of CL-depleted strains by restoring MRC supercomplex biogenesis 
and decreasing oxidative stress, both of which are key phenotypes associated with 
BTHS. Surprisingly, Etn-mediated rescue of CL-dependent respiratory phenotypes was 
found to be independent of PE biosynthesis, suggesting a novel role of Etn in rescuing 
the mitochondrial defects specific to CL deficient cells. 
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Results  
Ethanolamine Supplementation Rescues the Respiratory Growth of CL Deficient Cells 
Previous reports have shown that CL deficiency in yeast cells is accompanied by 
an increase in PE levels (Gu et; al., 2004; Zhong et. al., 2004; Tuller et al., 1998), 
suggesting a compensatory response to make up for the lack of CL. Therefore, we asked 
if further elevation of mitochondrial PE levels in CL deficient taz1Δ or crd1Δ cells could 
compensate for the loss of CL and rescue the respiratory growth defect observed in 
synthetic growth medium with ethanol as a carbon source (Ye et. al, 2014). To elevate 
mitochondrial PE levels, we utilized our recently described Etn supplementation strategy 
(Baker et. al, 2016) and found that 2 mM Etn rescued the respiratory growth defect of 
taz1Δ and crd1Δ cells in both solid and liquid growth media (Fig. 3.2A and B). Etn 
supplementation fully rescued the respiratory growth defect of CL-depleted taz1Δ cells 
and partially rescued the growth of CL-lacking crd1Δ cells (Fig. 3.2A and B). In order to 
rule out strain-specific effects, we also performed Etn supplementation experiments in a 
different mating-type strain and demonstrated similar respiratory growth rescue of CL-
deficient cells (Fig 3.3). 
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Figure 3.2 Ethanolamine supplementation rescues reduced respiratory growth of CL 
deficient yeast cells. 
(A) The growth of wildtype (WT), taz1Δ and crd1Δ cells in SC glucose, SC ethanol, and SC 
ethanol + 2 mM ethanolamine (Etn) media at 30°C (upper panel) and 37°C (lower panel) was 
monitored by measuring absorbance at 600 nm. Data are representative of at least three 
independent measurements. (B) Ten-fold serial dilutions of WT, taz1Δ and crd1Δ cells were 
seeded on to SC glucose, SC ethanol and SC ethanol + 2 mM Etn and (C) SC ethanol + 2 mM 
choline (Cho) or 2 mM propanolamine (Prn) and images were captured after 2 days of growth on 
SC glucose, 5 days of growth on SC ethanol ± Etn, Cho or Prn at 30°C, and 7 days of growth on 
SC ethanol ± Etn, Cho or Prn at 37°C. Data are representative of at least three independent 
experiments. 
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Figure 3.3 Ethanolamine supplementation rescues respiratory growth of CL-deficient cells 
in the BY4742 background. 
(A) The growth of BY4742 WT, taz1Δ and crd1Δ cells in SC glucose, SC ethanol, and SC 
ethanol + 2 mM ethanolamine (Etn) at 30°C (upper panel) and 37°C (lower panel) was 
monitored by measuring absorbance at 600 nm. Data are representative of at least three 
independent measurements. (B) Ten-fold serial dilutions of WT, taz1Δ and crd1Δ cells were 
seeded on to the indicated media and images were captured after 2 days of growth on SC 
glucose, 5 days on SC ethanol ± 2 mM Etn at 30°C, and 7 days on SC ethanol ± 2 mM Etn at 
37°C. Data are representative of at least three independent experiments. 
To determine the specificity of Etn-mediated rescue, we supplemented 
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biosynthesis of phosphatidylcholine, a major bilayer forming phospholipid of yeast cells, 
whereas Prn is a substrate for the non-natural, non-bilayer forming phospholipid 
phosphatidylpropanolamine (PP) (Storey et. al., 2001). We found that Prn 
supplementation rescued respiratory growth of taz1Δ and crd1Δ cells in a manner 
comparable to Etn, while Cho supplementation could not restore the respiratory growth 
of taz1Δ and crd1Δ cells (Fig. 3.2C). These results suggest a specific role of non-bilayer 
forming phospholipids or their precursors in compensating for the loss of CL. 
Ethanolamine Supplementation Increases Mitochondrial PE in CL Deficient Yeast Cells 
To confirm that Etn supplementation results in increased mitochondrial PE in 
taz1Δ and crd1Δ cells, we analyzed the mitochondrial phospholipid composition of cells 
grown with and without Etn. Consistent with the previous reports (Tuller et al., 1998, Gu 
et. al., 2004, Zhong et. al., 2004), mitochondrial phospholipid analysis of CL deficient 
cells revealed that, when compared to WT cells, PE was already elevated by 26% and 
50% in taz1Δ and crd1Δ cells, respectively (Fig. 3.4A). The addition of Etn to the media 
resulted in a further 25% increase of mitochondrial PE levels in taz1Δ cells with a 
concomitant decrease in PC levels and a small but significant increase in MLCL levels 
(Fig. 3.4A). In crd1Δ cells, neither PE nor PC was significantly altered upon Etn 
supplementation, although there was a trend towards increased PE/PC ratio (Fig. 3.4A). 
Like Etn, Prn supplementation resulted in increased mitochondrial non-bilayer to bilayer 
phospholipid ratio in taz1Δ cells, with phoshphatidylpropanolamine (PP) forming almost 
12% of total mitochondrial membrane phospholipids with a concomitant reduction in PC 
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(Fig. 3.4B). These results demonstrate that exogenous supplementation of phospholipid 
precursors Etn and Prn leads to increased levels of PE and PP in mitochondria. 
Figure 3.4 Ethanolamine and propanolamine supplementation elevates mitochondrial PE 
and PP levels in CL deficient cells.   
(A) The mitochondrial phospholipid composition of WT cells grown in SC ethanol and taz1Δ 
and crd1Δ cells grown in SC ethanol with and without ethanolamine (Etn). Data are expressed as 
mean ± S.D. (n=3), **P < 0.005, *P < 0.05, NS = Not significant. (B) The mitochondrial 
phospholipid composition of WT cells grown in SC ethanol and taz1Δ cells grown in SC ethanol 
with and without 2 mM propanolamine (Prn). Data are expressed as mean ± S.D. (n=3), **P < 
0.005, *P < 0.05, NS = Not significant. PE, phosphatidylethanolamine; CL, cardiolipin; PA, 
phosphatidic acid; PC, phosphatidylcholine; PI, phosphatidylinositol; PS, phosphatidylserine; 
PG, phosphatidylglycerol; PP, phosphatidylpropanolamine; MLCL, monolysocardiolipin. 
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Ethanolamine-Mediated Rescue of Respiratory Growth in CL Deficient Cells is 
Independent of PE Biosynthesis  
While significant elevation of PE in taz1Δ cells can explain the rescue of 
respiratory growth, the lack of a further increase in PE upon Etn supplementation in 
crd1Δ cells suggests that PE may not be responsible for the observed rescue. To test the 
role of PE in rescuing CL deficiency, we used lyso-PE supplementation, which activates 
an alternate pathway for mitochondrial PE elevation (Riekhof and Voelker, 2006) (Fig. 
3.1) and found that it did not rescue the respiratory growth of taz1Δ and crd1Δ cells (Fig. 
3.5). Notably, lyso-PE and Etn supplementation fully rescued the reduced respiratory 
growth of mitochondrial PE depleted psd1Δ cells, indicating that these PE precursors get 
incorporated into mitochondrial PE (Fig. 3.6). 
Figure 3.5 Lyso-PE supplementation does not rescue the respiratory growth of CL 
deficient cells.  
(A) The growth of WT, taz1Δ, and (B) crd1Δ cells cultured in SC ethanol, SC ethanol + 2 mM 
Etn, and SC ethanol + 0.5 mM LPE media at 30°C was monitored by measuring absorbance at 
600 nm. Data are representative of at least two independent measurements. 
crd1Δ 
crd1Δ+LPE 
crd1Δ+Etn 
A WT 
WT+Etn 
WT+LPE 
WT 
WT+Etn 
WT+LPE 
taz1Δ 
taz1Δ+LPE 
taz1Δ+Etn 
A 6
00
 n
m
A 6
00
 n
m
Time (hrs) Time (hrs) 
B
0
1
2
3
4
5
6
0 10 20 30 40 50
0
1
2
3
4
5
6
0 10 20 30 40 50
  68 
Figure 3.6 Lyso-PE supplementation rescues the respiratory growth of PE-deficient psd1Δ	
cells.  
The growth of WT cells grown in SC lactate and psd1Δ	cells grown in SC lactate, SC lactate + 2 
mM ethanolamine (Etn), and SC lactate + 0.5 mM lyso-PE (LPE) media at 30°C was monitored 
by measuring absorbance at 600 nm. Data are representative of at least two independent 
measurements. 
To completely rule out the requirement of PE biosynthesis from Etn 
supplementation, we deleted the gene encoding the rate-limiting enzyme of the Kennedy 
pathway, ethanolamine-phosphate cytidylyltransferase (Ect1), in taz1Δ and crd1Δ 
backgrounds. We analyzed the growth of taz1Δect1Δ and crd1Δect1Δ cells in respiratory 
media with and without Etn and observed that Etn supplementation rescued growth of 
the double mutants despite the absence of Ect1 (Fig. 3.7A and B). To confirm that the 
disruption of ECT1 abolished the increased PE levels observed with Etn 
supplementation, we measured the cellular PE levels in WT and individual single and 
double mutants with and without Etn supplementation. As expected in the ect1Δ genetic 
background, cellular PE did not increase with Etn supplementation (Fig. 3.7C). 
Together, these results suggest that Etn-mediated rescue of taz1Δ and crd1Δ cells is 
independent of PE biosynthesis and mediated by either Etn itself or its downstream 
metabolites. 
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Figure 3.7 Ethanolamine-mediated rescue of respiratory growth of CL deficient cells is 
independent of PE biosynthesis.  
(A) Ten-fold serial dilutions of WT, ect1Δ, taz1Δ, and taz1Δect1Δ cells and (B) WT, ect1Δ, 
crd1Δ, and crd1Δect1Δ cells were seeded on to the indicated media and images were captured 
after 2 days of growth on SC glucose, 5 days on SC ethanol ± 2 mM Etn at 30°C, and 7 days on 
SC ethanol ± 2 mM Etn at 37°C. Data are representative of at least three independent 
experiments. (C) Total cellular PE levels of the indicated strains grown in SC ethanol ± 2 mM 
Etn. Data are expressed as mean ± S.D. (n=3), *P<0.05, NS = Not significant. 
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The Kennedy pathway is not Required for the Ethanolamine-Mediated Rescue of the 
Respiratory Growth of taz1Δ and crd1Δ Cells 
To examine the requirement of the Kennedy pathway in Etn-mediated rescue of 
taz1Δ and crd1Δ cells, we deleted ethanolamine kinase (Eki1) and choline kinase (Cki1), 
the enzymes that catalyze the first step in Etn and Cho conversion to PE and PC, 
respectively (Fig. 3.1). Both Eki1 and Cki1 have been shown to utilize Etn as a substrate, 
converting it into phosphoethanolamine (PEtn) (Kim et al., 1999). Therefore, we 
constructed the triple mutant taz1Δeki1Δcki1Δ and analyzed its growth on respiratory 
media in the absence and presence of Etn. We found that Etn supplementation was able 
to rescue the reduced respiratory growth of taz1Δeki1Δcki1Δ cells in a manner similar to 
taz1Δ cells (Fig. 3.8A). This result suggests that Etn itself, not PEtn or the downstream 
metabolites of the Kennedy pathway, mediates the respiratory growth rescue observed in 
CL deficient cells. 
To determine if the import of Etn is necessary to rescue the observed growth 
defects, we performed co-supplementation assays with Cho because it negatively 
regulates the Etn importer (Fernández-Murray et al., 2013). Therefore, we supplemented 
the Etn-containing media with varying amounts of Cho and observed that the co-
supplementation almost completely inhibited Etn rescue in a dose-dependent manner 
(Fig. 3.8B). Taken together, these results suggest a specific role of Etn in alleviating the 
respiratory growth defect in taz1Δ and crd1Δ cells. 
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Figure 3.8 The Kennedy pathway metabolites are not required for the ethanolamine-
mediated rescue of respiratory growth of taz1Δ and crd1Δ cells. 
(A) Ten-fold serial dilutions of WT, eki1Δcki1Δ, taz1Δ, and eki1Δcki1Δtaz1Δ cells were seeded 
on to the indicated media and images were captured after 2 days of growth on SC glucose, 5 
days on SC ethanol ± 2 mM Etn at 30°C, and 7 days on SC ethanol ± 2 mM Etn at 37°C. Data 
are representative of at least three independent experiments. (B) Ten-fold serial dilutions of WT, 
taz1Δ, and crd1Δ cells were spotted on to SC glucose, SC ethanol, SC ethanol + 20 mM choline 
(Cho), SC ethanol + 2 mM Etn, and SC ethanol + 2 mM Etn in combination with the indicated 
amount of Cho and images were captured after 2 days of growth on SC glucose, and 7 days on 
SC ethanol ± Etn, Cho or both at 37°C. Data are representative of at least three independent 
experiments. 
Ethanolamine Supplementation Restores the Formation of Respiratory Supercomplexes 
in taz1Δ Cells 
CL deficiency disrupts MRC supercomplex formation (Zhang et al., 2002; 
Pfeiffer et al., 2003; Brandner et al., 2005). To determine if Etn-mediated rescue of 
respiratory growth is due to the restoration of supercomplexes, we examined 
supercomplex formation in taz1Δ cells. Etn supplementation in taz1Δ cells partially 
restored the formation of the large supercomplex (III2IV2) and reduced the amounts of 
free complex III dimer (III2) (Fig. 3.9A and B) and complex IV monomer (Fig. 3.9C and 
D). Etn supplementation did not result in alteration in the total amount of complex III 
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(Fig. 3.10A), but it did increase the total amount of complex IV (Fig. 3.10B). Consistent 
with the respiratory growth rescue, Prn supplementation also resulted in the restoration 
of MRC supercomplex formation in taz1Δ cells (Fig. 3.11). To determine if the Etn-
mediated restoration of supercomplex levels in taz1Δ cells was due to increased 
mitochondrial PE levels, we examined supercomplex formation in taz1Δect1Δ cells, 
which cannot synthesize PE via the Kennedy pathway. In a manner identical to taz1Δ 
cells, Etn was able to promote the formation of the large supercomplex in taz1Δect1Δ 
cells (Fig. 3.9E and F). These results clearly indicate that Etn promotes respiratory 
supercomplex formation in CL depleted taz1Δ cells independent of increased PE 
biosynthesis.   
  73 
Figure 3.9 Ethanolamine supplementation restores supercomplex formation in taz1Δ and 
taz1Δect1Δ cells.  
(A) Mitochondria from WT cells grown in SC ethanol and taz1Δ cells grown in SC ethanol ± 2 
mM Etn were solubilized by 1% digitonin and subjected to BN-PAGE/western blot analysis. 
Complexes containing MRC complex III were detected by anti-Rip1 antibody. (B) The relative 
abundance of MRC complex III containing complexes from (A) were quantified by 
densitometric analysis. Data are expressed as mean ± S.D. (n=3) (C) Samples from (A) were 
probed with anti-Cox2 antibody to detect MRC complex IV containing supercomplexes and free 
complex IV. (D) Relative abundance of MRC complex IV containing complexes from (C) were 
quantified by densitometric analysis. Data are expressed as mean ± S.D. (n=3) (E) Mitochondria 
from WT, taz1Δ, and taz1Δect1Δ cells grown in SC ethanol ± 2 mM Etn were solubilized by 1% 
digitonin and subjected to BN-PAGE/western blot analysis, and MRC complexes III and (F) IV 
were detected by probing with anti-Rip1 and anti-Cox2 antibodies, respectively. (III2IV2, large 
supercomplex; III2IV, small supercomplex; III2, complex III dimer and IV, free complex IV) 
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Figure 3.10 Ethanolamine supplementation elevates MRC complex IV levels in CL-
deficient taz1Δ	cells. 
(A) MRC complex III levels from BN-PAGE/western blots shown in Figure 3.9A and (B) MRC 
complex IV levels from BN-PAGE/western blots shown in Figure 3.9C were quantified by 
densitometric analysis. Data are expressed as mean ± S.D. (n=3) 
Figure 3.11 Propanolamine supplementation partially restores supercomplex formation in 
CL-deficient taz1Δ	cells. 
Mitochondria from WT cells grown in SC ethanol and taz1Δ	cells grown in SC ethanol with and 
without 2 mM propanolamine (Prn) were solubilized by 1% digitonin and subjected to BN-
PAGE/western blot analysis. Anti-Rip1 and anti-Cox2 antibodies detected mitochondrial 
respiratory chain supercomplexes containing complex III and complex IV, respectively. Data are 
representative of at least three independent experiments. 
Ethanolamine-Mediated Rescue of Mitochondrial Function is Specific to CL Deficiency 
Previous reports have shown that a complete lack of CL in crd1Δ cells results in 
a more pronounced decrease in supercomplex formation, and that CL is specifically and 
absolutely required for supercomplex reconstitution in vitro (Bazan et al., 2013). 
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Consistent with these reports, we found that supercomplex formation in crd1Δ cells was 
not restored with Etn supplementation (Fig. 3.12A-D). Interestingly, Etn 
supplementation increased the levels of the complex IV monomer as well as total 
complex IV levels in crd1Δ cells (Fig. 3.12C, D, and F), without altering the levels of 
complex III (Fig. 3.12E). In order to determine if the increased levels of complex IV 
upon Etn supplementation resulted in increased complex IV activity, we performed in-
gel activity measurements and observed the restoration of complex IV activity in crd1Δ 
mitochondria (Fig. 3.12G and H). These results indicate that Etn-mediated rescue of 
respiratory growth in crd1Δ cells could be due to restoration of complex IV activity and 
not supercomplex formation per se. 
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Figure 3.12 Ethanolamine supplementation restores MRC complex IV activity in crd1Δ 
cells.  
(A) Mitochondria from WT cells grown in SC ethanol and crd1Δ cells grown in SC ethanol ± 2 
mM Etn were solubilized by 1% digitonin and subjected to BN–PAGE/western analysis. MRC 
complex III containing complexes were detected by anti-Rip1 antibody. (B) Relative abundance 
of MRC complex III containing complexes from (A) were quantified by densitometric analysis. 
Data are expressed as mean ± S.D. (n=3). (C) Samples from (A) were probed with anti-Cox2 
antibody to detect MRC complex IV containing supercomplexes and free complex IV. (D) 
Relative abundance of MRC complex IV containing complexes from (C) were quantified by 
densitometric analysis. Data are expressed as mean ± S.D. (n=3). (E) Total levels of MRC 
complex III and (F) complex IV from samples (A) and (C) respectively. (G) Digitonin-
solubilized MRC complexes from WT and crd1Δ cells were separated by Clear Native (CN-
PAGE), followed by in-gel activity staining for complex IV. (H) In-gel activity of complex IV 
was quantified by densitometric analysis, and relative activity was plotted. Data were normalized 
to WT cells and expressed as mean ± SD (n = 3); *p < 0.05. 
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Recently, two respiratory supercomplex assembly factors, Rcf1 and Rcf2, were 
shown to associate with MRC complex III and IV, thereby stabilizing MRC 
supercomplex formation (Strogolova et al., 2012; Chen et al., 2012). In order to 
determine if Etn-mediated rescue of mitochondrial defects is specific to CL related 
deficiencies, we monitored the growth of rcf1Δ and rcf2Δ cells in non-fermentable media 
with and without Etn. Consistent with the previous report (Chen et al., 2012), rcf1Δ cells 
exhibited more pronounced growth defect compared to rcf2Δ cells in respiratory media 
(Fig. 3.13). However, Etn-supplementation failed to rescue the reduced respiratory 
growth of either rcf1Δ or rcf2Δ cells (Fig. 3.13). Finally, in order to determine if Etn 
supplementation could rescue the lack of a functional respiratory chain, we monitored 
the growth of sdh2Δ, bcs1Δ, shy1Δ, and atp12Δ cells, which are mutants defective in 
MRC complexes II-V respectively. We found that Etn supplementation did not rescue 
respiratory growth of these MRC mutants (Fig. 3.14). Together, these results suggest 
that Etn-mediated rescue of mitochondrial defects is specific to CL deficiency and not 
the lack of MRC assembly factors. 
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Figure 3.13 Ethanolamine supplementation does not rescue the respiratory growth defect 
of rcf1Δ	and rcf2Δ	cells. 
The growth of WT, rcf1Δ and rcf2Δ cells in SC glucose, SC ethanol, and SC ethanol + 2 mM 
ethanolamine (Etn) media was monitored at 30°C (upper panel) and 37°C (lower panel) by 
measuring absorbance at 600 nm. Data are representative of at least two independent 
measurements. 
Figure 3.14 Ethanolamine supplementation does not rescue the respiratory growth of 
mitochondrial respiratory chain mutants. 
(A) Ten-fold serial dilutions of WT, taz1Δ, sdh2Δ, bcs1Δ, shy1Δ, and atp12Δ cells were seeded 
on to plates containing the indicated media and images were captured after 2 days of growth on 
SC glucose and 5 days of growth on SC ethanol ± 2 mM Etn at 30°C. Data are representative of 
at least three independent experiments. (B) Mitochondria from YP galactose grown WT, sdh2Δ, 
bcs1Δ and shy1Δ cells were subjected to western bot analysis. Mitochondrial respiratory chain 
complexes II, III, and IV (CII, CIII, and CIV) were probed using anti-Sdh2, anti-Rip1, and anti-
Cox2 antibodies, respectively. Porin was used as a loading control. 
 
A 6
00
 n
m
Ethanol + EtnEthanolGlucose
30 oC
37 oC
A 6
00
 n
m
A 6
00
 n
m
A 6
00
 n
m
A 6
00
 n
m
A 6
00
 n
m
WT 
rcf1Δ 
rcf2Δ
WT 
rcf1Δ 
rcf2Δ
Time (hrs) Time (hrs) Time (hrs) 
Time (hrs) Time (hrs) Time (hrs) 
0
2
4
6
0 10 20 30 40 50
0
2
4
6
0 10 20 30 40 50
0
2
4
6
0 20 40 60 80
0
2
4
6
0 20 40 60 80
0
2
4
6
0 5 10 15 20
0
2
4
6
0 5 10 15 20
WT
taz1Δ
sdh2Δ
bcs1Δ
shy1Δ
atp12Δ
Ethanol + EtnEthanolGlucose
A B
sd
h2
Δ
bc
s1
Δ
sh
y1
Δ
W
T
Sdh2
Rip1
Cox2
Porin
CII
CIII
CIV
  80 
Ethanolamine Supplementation Reduces Protein Carbonylation in CL Deficient Cells 
One of the hallmarks of CL depletion and BTHS pathology across multiple 
model systems, including the yeast BTHS model taz1Δ, is increased oxidative stress 
(Chen et al., 2008; Hsu et al., 2015; Wang et al., 2014). To determine if Etn 
supplementation could alleviate oxidative stress in CL deficient cells, we measured 
cellular protein carbonylation, a sensitive indicator of oxidative stress (Chen et al., 
2008). Consistent with a previous report (Chen et al., 2008), we also observed that taz1Δ 
and crd1Δ cells had increased cellular protein carbonylation. Etn supplementation 
reduced protein carbonylation in both taz1Δ and crd1Δ cells (Fig. 3.15A). In order to 
determine if Etn-mediated reduction of protein carbonylation was independent of PE 
biosynthesis, we measured protein carbonylation in the double mutants taz1Δect1Δ and 
crd1Δect1Δ and found that Etn was still able to reduce carbonylation (Fig. 3.15B). 
Together, these results demonstrate that Etn supplementation reduces oxidative stress in 
taz1Δ and crd1Δ cells. 
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Figure 3.15 Ethanolamine supplementation reduces protein carbonylation in CL deficient 
cells.  
(A) WT, taz1Δ, and crd1Δ or (B) WT, ect1Δ, taz1Δect1Δ, and crd1Δect1Δ cells were grown in 
SC ethanol ± 2 mM Etn to early stationary phase, protein was extracted and protein 
carbonylation was measured as described in Materials and Methods. Data are expressed as mean 
± S.D. (n=3), **P < 0.005 and *P < 0.05. 
Discussion  
We report a novel role for the phosphatidylethanolamine precursor Etn in 
ameliorating mitochondrial dysfunction caused by perturbations in mitochondrial 
membrane phospholipid composition due to CL deficiency. We serendipitously 
discovered this new role of Etn while testing the hypothesis that elevating mitochondrial 
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PE by exogenous Etn supplementation could rescue mitochondrial defects of CL 
deficient BTHS yeast model. Here, we show that Etn ameliorates mitochondrial 
dysfunction in CL deficient cells without increasing PE levels. Specifically, Etn exerted 
its protective effect by restoring MRC supercomplex formation and reducing oxidative 
stress in CL depleted cells. Notably, Etn supplementation failed to alleviate the 
respiratory defects caused by the loss of MRC supercomplex assembly factors and thus, 
was specific to CL deficiency. 
While the phospholipid precursors including choline and inositol are known to 
influence cellular physiology by regulating the expression of phospholipid biosynthetic 
genes (Henry et al., 2012), very little is known about the role of Etn outside of its 
incorporation into PE. Previous work has shown that Etn and phosphoethanolamine can 
directly modulate mitochondrial function (Modica-Napolitano and Renshaw, 2004). In 
fact, pharmacological elevation of phosphoethanolamine by meclizine, an anti-nausea 
drug, has been shown to protect the kidney from the ischemia-reperfusion injury by 
altering mitochondrial bioenergetics (Kishi et al., 2015). Therefore, we asked whether 
Etn mediated its effect by incorporation into phosphoethanolamine. We addressed this 
question by constructing the triple knockout strain, taz1Δeki1Δcki1Δ, which cannot 
phosphorylate ethanolamine. Our results show that Etn supplementation was still able to 
rescue the respiratory deficient growth of the triple knockout cells, indicating that 
phosphethanolamine is unlikely to contribute to the observed rescue (Fig. 3.8). 
In order to understand the biochemical basis by which Etn restored the 
respiratory growth of CL depleted cells, we examined the formation and function of 
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MRC supercomplexes. Previous reports have shown that CL deficiency results in 
diminished MRC supercomplexes, leading to respiratory defects in both the yeast and 
mammalian models of BTHS (Brandner et al., 2005; McKenzie et al., 2006). 
Remarkably, exogenous supplementation of the soluble phospholipid precursor Etn was 
able to rescue MRC supercomplex levels in the CL-depleted mitochondrial membranes 
of taz1Δ cells (Fig. 3.9). Interestingly, there was no restoration of supercomplexes in 
crd1Δ cells (Fig. 3.12A-D), which are completely devoid of CL (Fig. 3.4). The lack of 
supercomplex formation in CL deficient crd1Δ cells grown in the presence of Etn 
suggests that a critical amount of CL is absolutely essential for supercomplex formation 
and may explain why Etn only partially rescued the respiratory growth of crd1Δ cells 
(Fig. 3.2). These findings are consistent with the in vitro supercomplex reconstitution 
experiments showing a specific requirement of CL for supercomplex assembly (Bazan et 
al., 2013; Mileykovskaya and Dowhan, 2014). 
One of the proposed roles of MRC supercomplex formation is to reduce the 
generation of reactive oxygen species by efficient substrate channeling (Acin-Perez and 
Enriquez, 2014; Genova and Lenaz, 2014). Consistent with this idea, increased oxidative 
stress has been observed in different models of BTHS, possibly due to reduced MRC 
supercomplex levels (Chen et al., 2008; Hsu et al., 2015; Wang et al., 2014). Our results 
show that Etn supplementation reduced protein carbonylation in taz1Δ and crd1Δ cells 
(Fig. 3.15). Interestingly, reduction in oxidative stress in crd1Δ cells was not 
accompanied by the restoration of supercomplex formation (Fig. 3.12). This finding not 
only raises questions about the physiological role of supercomplex formation, but also 
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about the cause(s) of increased oxidative stress in CL deficient cells. It is possible that 
the decreased MRC complex IV activity observed in crd1Δ cells leads to increased 
oxidative stress, which could explain why Etn-mediated restoration of complex IV 
activity concurrently reduced oxidative stress (Figs. 3.12G, H and 3.15). However, the 
cause-effect relationship between supercomplex biogenesis and oxidative stress has been 
difficult to determine because the two phenomena influence one another (Genova and 
Lenaz, 2014). 
The most important question raised by our study is how does Etn reduce 
oxidative stress and elevate MRC supercomplex levels in CL deficient taz1Δ cells. A 
number of physiological parameters have been shown to influence supercomplex 
formation. For example, the protein to phospholipid ratio of membranes governs the 
extent of supercomplex formation (Genova and Lenaz, 2014). In a recent study, 
increased complex IV biogenesis was shown to stabilize supercomplexes (Genova et al., 
2008). Similarly, we also observe an increase in complex IV levels upon Etn 
supplementation (Fig. 3.10), which provides a potential mechanism for increased 
supercomplex formation. The abundance of supercomplex formation is correlated with 
the unsaturation and homogeneity of CL species (Genova et al. 2008). Additionally, lipid 
peroxidation has also been suggested to regulate supercomplex formation (Genova and 
Lenaz, 2014). Finally, membrane shape has also been proposed to influence 
supercomplex formation (Cogliati et al., 2013). Etn may directly or indirectly affect any 
of these parameters to promote supercomplex formation. Lipidomic and microscopic 
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analysis of Etn supplemented cells could provide clues to the novel functions of Etn, 
experiments that are currently underway in our laboratory. 
While the precise mechanism by which Etn promotes supercomplex formation 
and reduces oxidative stress remains elusive at this time, a number of important 
conclusions can be drawn from this study. First, Etn mediates its effect on mitochondria 
- either directly or by incorporation into a yet unidentified metabolite that is not PE (Fig. 
3.7). Second, the protective effect of Etn is specific to CL deficiency because Etn-
supplementation fails to rescue mitochondrial dysfunction in cells lacking MRC 
assembly factors (Figs. 3.13 and 3.14). Third, Etn is able to overcome the accumulation 
of MLCL (Fig. 3.4), which has recently been shown to be the main cause of 
mitochondrial dysfunction in yeast models of BTHS (Ye et al., 2014; Bale et al., 2014). 
Henry and colleagues (Henry et al., 2012) predicted novel roles of lipid 
precursors in cellular physiology and suggested the suitability of the yeast 
Saccharomyces cerevisiae model system to uncover such processes. Our work, 
demonstrating a novel role of the soluble lipid precursor Etn in ameliorating 
mitochondrial dysfunction caused by CL deficiency in yeast model of BTHS, provides 
strong support for their prediction. 
Materials and Methods  
Yeast Strains, Growth Medium Composition, and Culture Conditions 
  Saccharomyces cerevisiae strains used in this study are listed in Table 3.1. These 
strains were confirmed by polymerase chain reaction as well as by replica plating on 
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dropout plates. Single and double knockout yeast strains were constructed by one-step 
gene disruption using hygromycin or clonNat (nourseothricin) resistance cassettes 
amplified from pFA6a-hphNT1 or pFA6a-natNT2 plasmids, respectively (Janke et al., 
2004). The primers used for one-step gene disruption are listed in Table 3.2. For growth 
in liquid media, strains were pre-cultured in YPD medium [1% yeast extract, 2% 
peptone, and 2% dextrose] and inoculated into SC media [0.2% dropout mix containing 
amino acid and other supplements as previously described (Amberg et al., 2005), 0.17% 
yeast nitrogen base without amino acids and ammonium sulfate, and 0.5% ammonium 
sulfate] containing either 2% glucose, 2% lactate (pH 5.5) or 2% ethanol and grown to 
late logarithmic phase. Solid media were prepared by the addition of 2% agar to the 
media described above. Yeast strains were inoculated into liquid SC glucose, SC lactate 
and SC ethanol at a starting at an optical density 0.1 at 600 nm and growth was 
monitored for up to 20 hrs (SC glucose), 40 hrs (SC lactate) or 80 hrs (SC ethanol) at 
30°C and 37°C. For growth on solid media, ten-fold serial dilutions of overnight pre-
cultures were seeded on SC glucose or SC ethanol plates and incubated at 30°C or 37°C 
for 2 days (SC glucose) and 5 or 7 days (SC ethanol), respectively. For Etn 
supplementation experiments, 2 mM Etn was added to SC growth medium. For media 
containing lyso-PtdEtn, 1% (v/v) Tergitol Nonidet P-40 was included, and lyso-PtdEtn 
was added to the final concentration of 0.5 mM from a sterile 25 mM stock solution in 
10% (v/v) Tergitol Nonidet P-40 (Riekhof and Voelker, 2006).  
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Table 3.1 Saccharomyces cerevisiae strains used in this study 
Yeast Stains Genotype Source 
BY4742 WT MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0 Greenberg, M.L. 
BY4742 taz1Δ MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, taz1Δ::hphNT1 This study 
VGY1 MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, crd1Δ::URA3 Greenberg, M.L. 
BY4741 WT MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 Greenberg, M.L. 
BY4741 taz1Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, taz1Δ::kanMX4 Open Biosystems 
BY4741 crd1Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, crd1Δ::kanMX4 Open Biosystems 
BY4741 psd1Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, psd1Δ::kanMX4 Open Biosystems 
BY4741 ect1Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, ect1Δ::hphNT1 This study 
BY4741 
taz1Δect1Δ 
MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
taz1Δ::kanMX4, ect1Δ::hphNT1 This study 
BY4741 
crd1Δect1Δ 
MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
crd1Δ::kanMX4, ect1Δ::hphNT1 This study 
BY4741 
eki1Δcki1Δ 
MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
eki1Δ::natNT2, cki1Δ::hphNT1 This study 
BY4741 
eki1Δcki1Δtaz1Δ 
MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
taz1Δ::kanMX4, eki1Δ::natNT2, cki1Δ::hphNT1 This study 
BY4741 sdh2Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, sdh2Δ::kanMX4 Open Biosystems 
BY4741 bcs1Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, bcs1Δ::kanMX4 Open Biosystems 
BY4741 shy1Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, shy1Δ::kanMX4 Open Biosystems 
BY4741 atp12Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, atp12Δ::kanMX4 Open Biosystems 
BY4741 rcf1Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, rcf1Δ::kanMX4 Open Biosystems 
BY4741 rcf2Δ MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, rcf2Δ::kanMX4 Open Biosystems 
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Table 3.2 Primers used in this study 
The bold face letters represent sequences that are complementary to the flanking sequences of 
the hygromycin and clonNat (nourseothricin) resistance cassettes of pFA6a-hphNT1 or pFA6a-
natNT2 plasmids, respectively. 
Name Sequence (5’ to 3’) 
TAZ1 S1  CATTTTCAAAAAAAAAAAAAGTAAAGTTTTCCCTATCAAATGCGTACGCTGCAGGTCGAC 
TAZ1 S2 TGAAATTTAAGCAATTAAATTCGTGTAAATACTAGCATGTAATCGATGAATTCGAGCTCG 
ECT1 S1 AATGCTTTACAGGATCGGGACTTGAAATATACTGACTGGATGCGTACGCTGCAGGTCGAC 
ECT1 S2 CCATTTAATTTACGTTCGAAGAAGTTTTCAACATTTGTTTAATCGATGAATTCGAGCTCG 
EKI1 S1 TAGCAGAAATTAACAGATACAGATCTGCAATTTGGCATAATGCGTACGCTGCAGGTCGAC 
EKI1 S2 ATCGCAGTGAATAGAAAAATACTTGATTGTGTATACAGCTTATCGATGAATTCGAGCTCG 
CKI1 S1 TACACACACATAGATACGCACGTAAAATTAGAGCAAAAGATGCGTACGCTGCAGGTCGAC 
CKI1 S2 TTATTTCCTTGGCCTTTGTTGAAGGAATTCGTATACGTATTATCGATGAATTCGAGCTCG 
Mitochondrial Isolation 
Isolation of crude and pure mitochondria was performed as described previously 
(Meisinger et al., 2006). Mitochondria were isolated from yeast cells grown to late 
logarithmic phase and were subsequently used for SDS-PAGE western blot analysis as 
well as in-gel activity assays. For obtaining gradient purified mitochondrial fractions, 
crude mitochondria were loaded onto a sucrose step gradient (60%, 32%, 23% and 15%) 
and centrifuged at 134,000 g for 1 h. The intact mitochondria recovered from the 
gradient interface (60% and 32%) were washed in isotonic buffer, pelleted at 10,000 g, 
and subsequently used for BN-PAGE/western blot analysis and mitochondrial 
phospholipid quantification. Protein concentrations were determined by the BCA assay 
(Thermo Scientific).  
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Cellular and Mitochondrial Phospholipid Measurements 
For the quantification of mitochondrial phospholipids, lipids were extracted from 
gradient purified mitochondria (1.5 mg protein) using the Folch method (Folch et al., 
1956), and individual phospholipids were separated by two-dimensional thin layer 
chromatography using the following solvent systems: chloroform/methanol/ammonium 
hydroxide (65:35:5) in first dimension followed by chloroform/acetic 
acid/methanol/water (75:25:5:2.2) in second dimension (Storey et al., 2001). 
Phospholipids were visualized with iodine vapor, scraped into glass tubes, and inorganic 
phosphate was quantified (Bartlett, 1959). For the quantification of cellular PE, 
phospholipids were extracted from yeast cells (0.5 g wet weight) using the Folch method 
(Folch et al., 1956), inorganic phosphate was quantified, 30 nmol of phospholipids were 
loaded onto HPTLC silica gel 60 plates (EMD Millipore 1.11764.0001) and individual 
phospholipids were separated by one-dimensional thin layer chromatography using 
chloroform/methanol/ammonium hydroxide (50:50:3) (Connerth et al., 2012). 
Phospholipids were visualized with copper sulfate charring and bands were quantified 
using ImageJ (Connerth et al., 2012). 
Sodium Dodecylsulfate and Blue Native PAGE and Immunoblotting 
Sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed on mitochondrial samples solubilized in lysis buffer (150 mM NaCl, 1 mM 
EDTA, 50 mM Tris–HCl, pH 7.4, 1% NP-40, 0.5% sodium deoxycholate and 0.1% 
SDS) supplemented with protease inhibitor cocktail (Roche Diagnostic). Protein extracts 
were separated on NuPAGE 4-12% Bis-Tris gels (Life-Technologies), transferred to 
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PVDF membranes using a Trans–Blot transfer cell (Bio-Rad). Membranes were blocked 
in 5% fatty acid-free BSA dissolved in Tris–buffered saline with 0.1% Tween 20 and 
probed with the indicated antibodies. Blue native polyacrylamide gel electrophoresis 
(BN-PAGE) was performed to separate native MRC complexes as previously described 
(Wittig et al., 2006). Briefly, yeast gradient purified mitochondria were solubilized in 
buffer containing 1% digitonin (Life-Technologies), and incubated for 15 min at 4°C. 
Following a clarifying spin at 20,000 × g (30 min, 4°C), 50x G-250 sample additive was 
added to the supernatant and 20 µg of protein was loaded on a 3-12% gradient native 
PAGE Bis–Tris gel (Life-Technologies). Western blot was performed using a Mini-
PROTEAN Tetra cell (Bio-rad). The membrane was blocked in 5% nonfat milk in Tris–
buffered saline with 0.1% Tween 20 and probed with antibodies as indicated. Primary 
antibodies used for yeast proteins were: Cox2, 1:50,000 (Abcam 110 271); Sdh2, 
1:5,000 (from Dr. Dennis Winge); Rip1, 1:100,000 (from Dr. Vincenzo Zara); Porin, 
1:100,000 (Abcam 110 326). Anti-mouse (NA93IV) and anti-rabbit (32460) secondary 
antibodies (1:5,000) were incubated for 1 h at room temperature, and membranes were 
developed using Western Lightning Plus-ECL (PerkinElmer). Quantification was 
performed using the gel analysis method in ImageJ. 
In-Gel Activity Measurements 
In-gel activities for mitochondrial respiratory chain complexes were performed 
as described previously (Wittig et al., 2007). Clear Native Polyacrylamide Gel 
Electrophoresis (CN-PAGE) was used to avoid interference of Coomassie blue with 
activity measurements. Briefly, mitochondria solubilized in 1% digitonin were resolved 
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on a 4-16% gradient native PAGE Bis– Tris gel (Life-Technologies) with the addition of 
0.05% n-dodecyl β-D-maltoside and 0.05% sodium deoxycholate in the cathode buffer. 
Gels were loaded with 90 µg of protein and incubated in MRC complex IV activity 
staining solutions as reported previously (Wittig et al., 2007). Equal loading was 
determined by Coomassie blue stain, and total protein and band intensity quantification 
was determined using the gel analysis method in ImageJ. 
Quantification of Protein Carbonyl Content 
The protein carbonyl content was measured by determining the amount of 2,4-
dinitrophenylhydrazone (DNP) formed upon reaction with 2,4-dinitrophenyl hydrazine 
(DNPH), as described previously (Reznick and Packer, 1994; Dirmeier et al., 2004; 
Chen et al., 2008). Yeast cells were grown at 30°C to the early stationary phase in SC 
ethanol, harvested and cell extracts were used for subsequent protein carbonylation 
measurements. Nucleic acids were removed from the cell extracts with 1.0% 
streptomycin sulfate, and the resulting protein samples were incubated with 10 mM 
DNPH in 2 M HCl at room temperature for 60 min in the dark. Proteins were 
precipitated by addition of trichloroacetic acid to a final concentration of 10%, and the 
pellets were washed with ethanol/ethyl acetate (1:1) to remove the free DNPH. The final 
protein pellets were dissolved in 6 M guanidine hydrochloride solution containing 
20 mM potassium phosphate, pH 2.4. The carbonyl content was calculated from the 
absorbance maximum of DNP measured at 370 nm. 
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CHAPTER IV  
MECLIZINE INHIBITS MITOCHONDRIAL RESPIRATION THROUGH DIRECT 
TARGETING OF CYTOSOLIC PHOSPHOETHANOLAMINE METABOLISM* 
Disclaimer 
 The work described in this chapter comprises reprints of a publication to 
which I contributed as a third author. The summary is a reprint of the publication 
abstract and the rest of the sections are as published. Figure contribution in this 
publication: Fig. 4.1D, Fig. 4.4E, Fig. 4.6, and Fig. 4.7.  
* This research was originally published in Journal of Biological Chemistry. Gohil V.M.,
Zhu L., Baker C.D., Cracan V., Yaseen A., Jain M., Clish C.B., Brookes P.S., Bakovic M., Mootha V.K. 
Meclizine Inhibits Mitochondrial Respiration Through Direct Targeting of Cytosolic 
Phosphoethanolamine Metabolism. J. Biol. Chem. 2013; 49:35387-35395 © the American Society for 
Biochemistry and Molecular Biology. 
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Summary 
 We recently identified meclizine, an over-the-counter drug, as an inhibitor of 
mitochondrial respiration. Curiously, meclizine blunted respiration in intact cells, but not 
in isolated mitochondria, suggesting an unorthodox mechanism. Using a metabolic 
profiling approach, we now show that treatment with meclizine leads to a sharp 
elevation of cellular phosphoethanolamine, an intermediate in the ethanolamine branch 
of the Kennedy pathway of phosphatidylethanolamine biosynthesis. Metabolic labeling 
and in vitro enzyme assays confirm direct inhibition of the cytosolic enzyme 
CTP:phosphoethanolamine cytidylyltransferase (Pcyt2). Inhibition of Pcyt2 by meclizine 
leads to rapid accumulation of its substrate phosphoethanolamine, which is itself an 
inhibitor of mitochondrial respiration. Our work identifies the first pharmacologic 
inhibitor of the Kennedy pathway, demonstrates that its biosynthetic intermediate is an 
endogenous inhibitor of respiration, and provides key mechanistic insights that may 
facilitate repurposing meclizine for disorders of energy metabolism. 
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Introduction 
Although mitochondrial respiration is crucial for cellular energetics and redox 
balance, during certain pathological conditions respiration can actually contribute to 
pathogenesis (Vafai and Mootha, 2012). Attenuation of mitochondrial respiration has 
been proposed as therapeutic strategy in a number of human disorders, including 
ischemia-reperfusion injury, neurodegeneration, autoimmune disease, and cancer 
(Armstrong, 2007). Many naturally occurring as well synthetic compounds targeting the 
mitochondrial respiratory chain are available, but their clinical utility is limited by their 
narrow therapeutic index (Dykens and Will, 2007); thus, there is an unmet need for 
discovering new classes of drugs that can safely modulate mitochondrial respiration. 
We recently identified meclizine, an over-the-counter anti-nausea drug, in a 
‘nutrient-sensitized’ chemical screen aimed at identifying compounds that attenuate 
mitochondrial respiration (Gohil et al., 2010). In vivo follow-up studies demonstrated 
that meclizine could be protective against heart attack (Gohil et al., 2010), stroke (Gohil 
et al., 2010), and neurodegeneration (Gohil et al., 2011) in animal models. Meclizine is a 
first-generation piperazine class of H1-antihistamine that has been in use for decades for 
prophylaxis against nausea and vertigo (Cohen and DeJong, 1972). Like many H1-
antihistamines, meclizine has anti-cholinergic activity, (Kubo et al., 1987) and it has also 
been shown to target constitutive androstane receptors (Huang et al., 2004).  
Meclizine’s inhibition of respiration had not been reported before, and unlike 
classical respiratory inhibitors (e.g., antimycin, rotenone), meclizine did not inhibit 
respiration in isolated mitochondria, but rather, only in intact cells (Gohil et al., 2010). 
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We previously reported that this effect was independent of its anti-histaminergic and 
anti-cholinergic activity (Gohil et al., 2010), but the precise mechanism remained 
unknown. Curiously, the kinetics of meclizine-mediated inhibition of respiration were on 
the time-scale of minutes (Gohil et al., 2010), far too fast for a transcriptional 
mechanism, but slower than direct inhibitors of the respiratory chain, suggesting that the 
inhibition arose from a potentially novel mechanism, perhaps through intracellular 
accumulation of a meclizine-derived active metabolite, or by perturbing metabolism. 
To gain insights into the mechanism of meclizine action, we performed global 
metabolic profiling of meclizine treated cells to detect alterations in intracellular 
metabolites of intermediary metabolism. Metabolic profiling revealed a sharp increase in 
intracellular levels of phosphoethanolamine (PEtn), an intermediate in the CDP-
ethanolamine (Etn) Kennedy pathway of phosphatidylethanolamine (PE) biosynthesis. 
Follow up biochemical experiments confirmed the direct inhibition of 
phosphoethanolamine cytidylyltransferase (PCYT2), a rate-limiting enzyme of CDP-Etn 
Kennedy pathway. The inhibition of PCYT2 results in the buildup of its substrate, PEtn, 
which itself directly inhibits mitochondrial respiration. Our work thus identifies a novel 
molecular target of meclizine and links the CDP-Etn Kennedy pathway to mitochondrial 
respiration. 
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Materials and Methods 
Metabolite Profiling 
Metabolite profiling was performed on MCH58 fibroblasts following treatment 
with 50 µM meclizine or vehicle control for five hours, using methods similar to those 
previously described (Shaham et al., 2010). Briefly, low passage MCH58 cells were 
cultured on 6-cm tissue culture dishes in 4 mL of culture media to 90% confluency and a 
final yield of 1x106 cells. For assessment of intracellular metabolites, media was 
aspirated from the above tissue culture dishes and cells were gently washed with 4 mL of 
phosphate buffered saline (PBS), to ensure complete removal of residual media 
metabolites. After removal of PBS cellular metabolism was quenched with immediate 
addition of 1 mL of pre-cooled (-80oC) methanol extraction solution (80% methanol, 
20% H2O). Cells were scraped in extraction solution, vortexed, centrifuged and the 
resulting supernatant was collected and stored at -80oC. At the time of measurement, 100 
µl of supernatant was diluted 1:1 with methanol extraction solution. The resulting 
solution was evaporated under nitrogen and the samples were reconstituted in 60 µl of 
high-performance liquid chromatography (HPLC)-grade water and metabolites assessed. 
Six biological replicates were assessed for each group. Analyses of endogenous 
metabolites were performed using a liquid chromatography tandem mass spectrometry 
(LC-MS) system composed of a 4000 QTRAP triple quadrupole mass spectrometer (AB 
SCIEX) coupled to three Agilent 1100 binary HPLC pumps (Agilent Technologies) and 
an HTS PAL autosampler (LEAP Technologies) equipped with three injection ports and 
a column selector valve. Three multiplexed chromatographic methods were configured 
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for the analyses of each sample: LC method 1 used a Luna Phenyl-Hexyl column 
(Phenomenex) with a linear gradient of water/acetonitrile/acetic acid (initial proportions 
100/0/0.001, final proportions 10/90/0.001); LC method 2 used a Luna NH2 column 
(Phenomenex) with a linear gradient using acetonitrile/water containing 0.25% 
ammonium hydroxide and 10 mM ammonium acetate (acetonitrile/water proportions 
were 80/20 at the beginning of the gradient and 20/80 at its conclusion); LC method 3 
used a Synergi Polar-RP column (Phenomenex), gradient elution with 5% acetonitrile/5 
mM ammonium acetate (mobile phase A) and 95% acetonitrile/5 mM ammonium 
acetate (mobile phase B). MS data were acquired using multiple reaction monitoring 
(MRM) in both the positive (LC method 1) and negative (LC methods 2 and 3) ion 
modes. During the development of this method, authentic reference compounds were 
used to determine LC retention times and to tune MRM transitions. Metabolite 
quantification was performed by integrating peak areas for specific MRM transitions 
using MultiQuant software (version 1.1; AB SCIEX), and all integrated peaks were 
manually reviewed for quality. Extraction and quantification procedures were optimized 
prior to assessment of samples in this study to ensure measured intracellular and media 
metabolites were within the linear range of detection. Confirmation of the PEtn peak was 
performed using an exogenous PEtn standard (Sigma P0503). The relative quantification 
of PEtn in MCH58 skin fibroblasts or mouse striatal cells (STHdhQ7/7) was also 
confirmed using hydrophilic interaction liquid chromatography (HILIC) (Roberts et al., 
2012). 
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Determination of the Intracellular Concentration of PEtn and Phosphocholine (PCho) 
 Intracellular concentration of PEtn and PCho in meclizine treated MCH58 
fibroblasts and PCYT2 knockdown cells was determined as follows: MCH58 fibroblast 
cells were seeded into a 6-well plate (0.2 x 106 cells/well). After 20h of growth, three 
wells were treated with 50 µM meclizine and the three remaining wells were treated with 
DMSO for approximately 5h. Cells were scraped, collected in methanol extraction 
solution (80% methanol, 20% H2O), and PEtn and PCho levels were quantified by LC-
MS using commercially available standards. Cell number and mean cellular diameter of 
MCH58 cells were determined using a Beckman Coulter Z-series cell counter in a 
parallel plate, which was subsequently used to calculate the intracellular concentration of 
PEtn and PCho. 
Radiolabeling of Kennedy Pathway Intermediates 
Radiolabeling of CDP-Etn Kennedy pathway intermediates was performed as 
described previously (Zhu et al., 2008). Briefly, MCH58 fibroblasts were cultured in the 
presence of 50 µM meclizine for 5h to 60% confluency at which point 14C-Etn (0.5 
µCi/dish) was added and cells were further incubated for 24h. Lipids were extracted 
using the method of Bligh and Dyer (Bligh and Dyer, 1959). The total radioactivity from 
the water/methanol phase and that of the lipid phase were measured separately. 14C-PE 
was separated from the lipid phase using TLC in a solvent consisting of 
methanol/chloroform/ammonia (65/35/5). Etn, PEtn, and CDP-Etn were separated from 
the water/methanol phase using TLC in a solution of methanol/0.5% NaCl/ammonia 
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(50/50/5). The separated 14C labeled compounds were measured by scintillation 
counting. 
PCYT2 Enzyme Assay 
Pcyt2 activity was assayed as described previously with minor modifications (Tie 
and Bakovic, 2007). Briefly, a 50 µl mixture of 20 mM Tris-HCl buffer, pH 7.8, 10 mM 
MgCl2, 5 mM DTT, 650 µM CTP, 650 µM unlabeled PEtn, and 65 µM 14C-PEtn was 
incubated with 0.4 µg of purified Pcyt2 at 37°C for 15min. Reactions were terminated by 
boiling for 2min. Meclizine was added at the indicated concentration in the reaction 
mixture. Reaction mixtures were then loaded onto silica gel G plates with CDP-Etn and 
PEtn standards and separated in a solvent system of methanol/0.5% NaCl/ammonia 
(50/50/5). Plates were then sprayed with 1% ninhydrin, and the CDP-Etn product was 
quantified by liquid scintillation counting. 
Construction of PCYT2 Knockdown Cell Lines 
The shRNA constructs targeting Pcyt2 were purchased from Open Biosystems 
and the empty vector pLKO.1 was obtained from The Broad Institute (Cambridge, MA). 
Five independent shRNAs were used to construct MCH58 knockdown cell lines. We 
chose the two best knockdowns cell lines to perform radiolabeling and bioenergetics 
assays. The shRNA sequences for the two best knockdowns are (kd1: 
5’CCCATCATGAATCTGCATGAA3’, kd2: 5’TCACGGCAAGACAGAAATTAT3’). 
The lentiviral particles were produced in HEK293T cells as described previously 
(Moffat et al., 2006). Infection of MCH58 fibroblasts with lentiviral particles, selection 
  100 
in puromycin (2 µg/ml) and their expansion to make stable knockdowns was performed 
essentially as described before (Gohil et al., 2010). The PCYT2 mRNA levels in 
knockdowns were quantified by qRT-PCR using TaqMan assay (Applied Biosystems). 
Bioenergetic Assays 
Oxygen consumption rate (OCR, a measure of mitochondrial respiration) and 
extracellular acidification rate (ECAR, a measure of glycolysis) measurements in intact 
cells were carried out as previously described (Gohil et al., 2010; Gohil et al., 2010) with 
minor modifications. Briefly, MCH58 fibroblasts (control and PCYT2 knockdowns) 
were seeded in XF24-well cell culture microplates (Seahorse Bioscience) at 30,000 
cells/well in 25 mM glucose containing DMEM media and incubated at 37°C/ 5% CO2 
for ~ 20h. Prior to the measurements, the growth medium was replaced with ~925 µL of 
assay medium (Seahorse Bioscience). The cells were incubated at 37°C for 60min in the 
assay medium prior to OCR/ECAR measurements. The measurements were performed 
simultaneously every 7min after a 2min mix and 2min wait period. Three baseline 
OCR/ECAR measurements were recorded prior to the addition of 50 µM meclizine 
dihydrochloride (MP Biomedical 155341). To test the effect of PEtn in vitro, 
mitochondria were isolated from C57BL/6 mouse kidneys as previously described 
(Gohil et al., 2010). Simultaneous monitoring of oxygen consumption, membrane 
potential, NADH and FAD+ fluorescence were performed using a custom made 
spectrophotometer. Reaction mixture contained in 0.5 ml of buffer A (137 mM KCl, 10 
mM HEPES pH 7.4, 2.5 mM MgCl2, 0.1% BSA) mitochondria (0.35 mg/ml) and 
tetramethylrhodamine methyl ester (TMRM) (0.5 µM). During the experiment 
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glutamate/malate (4.6 mM), ADP (180 µM) and PEtn (0, 3.2 mM, 8 mM) were added. 
The following excitations wavelengths were used for NADH, FAD+ and TMRM: 365 
nm, 470 nm and 530 nm. Data was acquired by integrating emission signals at 430-480 
nm, 520-560 nm and 580-600 nm for NADH, FAD+ and TMRM, respectively. For traces 
showing oxygen consumption of purified mitochondria in the presence of PCho, 0.5 ml 
of buffer A contained kidney mitochondria (0.2 mg/ml), glutamate/malate (4.6 mM), 
ADP (200 µM) and PCho (0-8 mM). Since PCho was commercially available only as a 
Ca2+ salt, a 160 mM stock was prepared in 500 mM EGTA/H2O solution.  
 Determination of IC50 for PEtn Inhibition of Mitochondrial Oxygen Consumption 
 MitoXpress oxygen sensitive probe (Luxcel Biosciences, Ireland) was used to 
monitor glutamate/malate-driven respiration of mouse kidney mitochondria in 96-well 
plate format (Will et al., 2006). Each well contained glutamate/malate (11.5 mM), 20 µl 
of MitoExpress probe (dry probe was dissolved in 1 ml of water), mitochondria (0.5 
mg/ml), PEtn (0-50 mM) in 200 µl total volume of buffer A. Two injections of ADP 
(487 µM final) were made using the injector of EnVision 2104 plate reader (Perkin-
Elmer, MA). Time-resolved fluorescence (TR-F) was measured with the following 
settings: delay and gate times 70 µs and 30 µs respectively. Data analysis was performed 
using SigmaPlot 12.3. Briefly, slopes of basal respiration (state 2) and ADP-activated 
respiration (state 3) were taken, and the data was normalized against maximum 
respiration with no PEtn. 
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PE Determination 
MCH58 fibroblasts were treated with 50 µM meclizine or DMSO for 5h. 
Mitochondria were isolated from approximately 1.5 g of cells (wet weight) using the 
Mitochondria Isolation Kit for Cultured Cells (Abcam MS852). Total phospholipids 
were extracted from whole cells or isolated mitochondria (1.5 mg of mitochondrial 
protein) as described previously (Folch et al., 1956). Briefly, phospholipids were 
extracted in 3 mL of chloroform/methanol (2:1) by shaking for 1hr, followed by addition 
of 600 µL of 0.9% NaCl solution and vortexing for an additional 15min. The aqueous 
and organic layers were separated via centrifugation (300 xg, 5min) followed by an 
additional wash with 500 µL of H2O. The bottom layer (organic phase) was evaporated 
to dryness under N2 gas. The resulting lipid film was resuspended in 90 µL of 2:1 
chloroform/methanol and separated on silica gel 60 TLC plates (EMD Millipore 
1.05721.0001) using a solvent system consisting of chloroform/acetic 
acid/methanol/water (75/25/5/2.2). The TLC plates were then dried and exposed to 
iodine vapor to visualize phospholipid spots. The identity of each spot was verified using 
phospholipids standards (Sigma PH9-1KT). Individual spots were scrapped and 
phospholipid phosphorus was quantified using the Bartlett method (Bartlett, 1959). 
Testing the Combined Effect of Meclizine and Etn on MCH58 Fibroblast ATP Levels 
 MCH58 fibroblasts were seeded at 10,000 cells/well in a 96-well plate in DMEM 
high glucose medium and allowed to grow overnight. After ~ 20h, growth medium was 
replaced with 10 mM galactose medium containing different concentrations of meclizine 
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(0, 12.5, 25, 50 µM) and Etn (0, 0.2, 1 and 5 mM). The ATP levels in the cells were 
measured by CellTiter-Glo reagent (Promega) 24h after the treatment. 
Results 
Meclizine Treatment Results in the Elevation of PEtn across Multiple Mammalian Cell 
Types 
To decipher the mechanism by which meclizine blunts respiration we used a 
metabolomics approach, since previous reports have shown that the technology can 
reveal targets of desired and undesired actions of drugs (Webhofer et al., 2011, Watkins 
and German, 2002). We performed mass spectrometry-based metabolic profiling of 
human immortalized skin fibroblasts (MCH58) cells treated with 50 µM meclizine for 
5h. Our choice of MCH58 immortalized human skin fibroblasts was guided by our 
previous study characterizing the effect of meclizine on mitochondrial energy 
metabolism (Gohil et al., 2010). Of the 124 metabolites that were measured reproducibly 
across 6 biological replicates, the most striking change corresponded to PEtn signal, 
which increased nearly 35-fold (P-adj<0.005), well outside the background distribution 
(Fig. 4.1A). We further confirmed the identity and up regulation of PEtn levels using 
HILIC-mass spectrometry in human fibroblasts and mouse striatal cells (Fig. 4.1B). 
These data are consistent with our previous observation showing that meclizine 
attenuates respiration across multiple cell types (Gohil et al., 2010). Using PEtn 
standards, we quantified the absolute levels of PEtn in fibroblasts and showed that 
within 5h of meclizine treatment the intracellular concentration of PEtn increases from 
approximately 1.5 mM to 4 mM (Fig. 4.1C and D).   
  104 
Figure 4.1 Phosphoethanolamine is elevated in meclizine treated cells. 
(A) Mass-spectrometry based quantification of 124 intracellular metabolites from MCH58 
human fibroblasts treated with 50 µM meclizine for 5h. Each data point represents an average of 
6 values for DMSO and meclizine treated samples. (B) Hydrophilic interaction liquid 
chromatography (HILIC)/mass-spectrometry based relative quantification of PEtn from human 
fibroblasts (MCH58) or mouse striatal cells (STHdhQ7/7) treated with DMSO or 50 µM 
meclizine for 5h. Data are expressed as mean ± S.D (n=6 for fibroblasts; n=3 for striatal cells). 
(C) The calibration curve used for the quantitative analysis of PEtn in meclizine treated samples 
was obtained by LC-MS using PEtn standards. (D) The cellular concentration of PEtn in MCH58 
fibroblasts treated with meclizine (50 µM) or DMSO was determined by counting cell number, 
calculating total cellular volume using Beckman Coulter Z-series cell counter and measuring 
absolute PEtn levels by mass-spectrometry. Data are expressed as mean ± S.D. (n=3). 
The Pattern of CDP-Etn Kennedy Pathway Intermediates in Meclizine-treated Cells Is 
Consistent with PCYT2 Inhibition 
PEtn is an intermediate in the CDP-Etn Kennedy pathway of PE biosynthesis 
(Vance, 2008; Pavlovic and Bakovic, 2013). The mammalian CDP-Etn Kennedy 
pathway consists of three enzymatic steps: Etn is first phosphorylated by Etn kinase 
(EK) to PEtn, which is converted to cytidine diphospho-Etn (CDP-Etn) by 
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CTP:phosphoethanolamine cytidylyltransferase (PCYT2 also referred to as ECT), finally 
Etn phosphotransferase (CEPT1) catalyzes the CDP-Etn conversion to PE (Fig. 4.2A). 
To understand why PEtn levels rise with meclizine, vehicle and meclizine treated cells, 
were incubated with 14C-Etn for 24h, and the incorporation of the radiolabel was 
measured in the intermediates of the CDP-Etn Kennedy pathway. With meclizine 
treatment, 14C-PEtn levels were increased while radiolabel incorporation into 
downstream metabolites, CDP-Etn and PE, were decreased (Fig. 4.2B). These results 
raise the hypothesis that meclizine directly blocks PCYT2 enzymatic activity, which 
catalyzes the conversion of PEtn to CDP-Etn. 
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Figure 4.2 Metabolic labeling of Kennedy pathway intermediates. 
(A) Enzymatic reactions depicting synthesis of Kennedy pathway intermediates. (B) 
Quantification of radiolabeled Kennedy pathway intermediates in meclizine treated MCH58 
fibroblasts. MCH58 fibroblasts were cultured in the presence of 50 µM meclizine or DMSO for 
5h at which point 14C-Etn (0.5 µCi/dish) was added and cells were further incubated for 24h. The 
14C labeled compounds were separated as described under “Experimental Procedures” and 
measured by scintillation counting. Data are expressed as mean ± S.D. (n=5). 
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Meclizine Is a Non-competitive Inhibitor of PCYT2 
 To confirm whether meclizine directly inhibits Pcyt2, we performed an in vitro 
enzyme assay with purified recombinant mouse Pcyt2 (Tie and Bakovic, 2007) in the 
presence of varying concentrations of meclizine. Meclizine inhibited Pcyt2 enzyme 
activity in a dose dependent manner (Fig. 4.3A), and the Lineweaver-Burke plot of the 
Pcyt2 enzyme kinetics suggests a non-competitive inhibition with an approximate Ki of 
31 µM (Fig. 4.3B).  
Figure 4.3 Meclizine inhibits recombinant purified Pcyt2. 
(A) In vitro activity of Pcyt2 (0.4 µg) measured using 650 µM CTP, 650 µM PEtn and 65 µM 
14C-labeled PEtn (55 µCi/µmol) in the presence of varying meclizine concentrations. (B) 
Inhibition kinetics of Pcyt2 with PEtn at a fixed concentration of 650 µM and 65 µM 14C-labeled 
PEtn (55 µCi/µmol) in the presence of varying concentrations of CTP (100-1000 µM) and 
meclizine (0-150 µM). All experiments were performed twice in duplicates. Data are expressed 
as mean ± S.D. 
PCYT2 Knockdown Cells Partially Mimic the Meclizine Effect 
We next sought to phenocopy the effects of meclizine using RNAi against 
PCYT2. We stably silenced PCYT2 in MCH58 human skin fibroblasts using five hairpins 
and focused on two hairpins that achieved 77% and 90% knockdown at the RNA level 
(Fig. 4.4A). We treated control and knockdown cells with 14C-Etn and quantified CDP-
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Etn Kennedy pathway intermediates. As expected, we observed an increase in 14C-PEtn 
levels and a decrease in downstream PCYT2 products 14C-CDP-Etn and 14C-PE, though 
the magnitude of changes was not as striking as with meclizine (Fig. 4.4B). The best 
knockdown of PCYT2 showed a slight reduction in basal oxygen consumption, and a 
corresponding increase in glycolysis (Fig. 4.4C); though, the magnitude of effect was 
small when compared to meclizine treated fibroblasts (Fig. 4.4D). This difference 
between chemical inhibition of Pcyt2 by meclizine and genetic depletion of PCYT2 by 
shRNA was consistent with our observation that a stable PCYT2 knockdown is 
incomplete and does not result in the sustained accumulation of PEtn (Fig. 4.4E).   
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Figure 4.4 Characterization of PCYT2 knockdown cells. 
(A) PCYT2 mRNA quantified by performing qRT-PCR on RNA extracted from MCH58 
fibroblasts infected with an empty vector (Control) or 2 independent shRNAs (kd1 and kd2) 
targeting PCYT2. (B) Quantification of the Kennedy pathway intermediates in control and 
PCYT2 knockdown fibroblasts. Experiments were done two times independently in triplicates, 
P<0.05 as determined by t-Test. (C) Ratio of OCR, a measure of mitochondrial respiration, to 
ECAR, a measure of glycolysis, in control and PCYT2 knockdown fibroblasts. Data are 
expressed as mean ± S.D. (n ≥ 5). (D) OCR to ECAR ratio in vehicle (DMSO) or meclizine (50 
µM) treated fibroblasts. Data are expressed as mean ± S.D. (n ≥ 4). (E) The cellular 
concentration PEtn in control and PCYT2 knockdown fibroblasts was determined by counting 
cell number, calculating total cellular volume using Beckman Coulter Z-series cell counter and 
measuring absolute PEtn levels by mass spectrometry. Data are expressed as mean ± S.D. (n=3). 
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PEtn Inhibits Respiration in Suspensions of Isolated Mitochondria 
It is notable that a previous study showed that Etn and PEtn can directly inhibit 
respiration in isolated suspensions of mitochondria (Modica-Napolitano and Renshaw, 
2004), raising the hypothesis that meclizine is blunting respiration in vivo via an 
elevation of PEtn. We found that PEtn does not impact basal (state 2) mitochondrial 
respiration, but indeed, has a strong inhibitory effect on ADP-stimulated (state 3) 
respiration (Fig. 4.5A), with an IC50 of 3.13 ± 0.54 mM. PEtn inhibited ADP-driven 
respiration either with glutamate/malate (Fig. 4.5A and B) or with succinate/rotenone 
respiration (data now shown), suggesting that the inhibitory effect is not specific to 
respiratory complex I or complex II or to a specific fuel substrate. In assays for 
mitochondrial physiology we find that the addition of PEtn leads to decreased NADH 
and increased FAD+ intrinsic fluorescence together with reduction of membrane 
potential (Fig. 4.5B). Notably, similar concentrations of phosphocholine (PCho), an 
intermediate in the CDP-Choline branch of the Kennedy pathway of phosphatidylcholine 
biosynthesis, did not inhibit respiration in suspensions of isolated mitochondria 
indicating that the inhibitory effect of PEtn on mitochondrial respiration was specific 
(Fig. 4.5C). Moreover, we also measured PCho levels in order to determine if meclizine 
mediated elevation of PEtn is due to the specific inhibition of PCYT2. We observed a 
decrease in the cellular concentration of PCho from 6.14 ± 0.43 mM to 2.79 ± 0.37 mM 
with meclizine treatment, making PCho an unlikely contributor to meclizine’s effect on 
mitochondrial respiration in vivo.  
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Figure 4.5 Effects of phosphoethanolamine on mitochondrial bioenergetics. 
(A) The effect of increasing PEtn concentrations on glutamate/malate-driven ADP-activated 
respiration (●) and basal respiration (○) in isolated mouse kidney mitochondria. Rates of oxygen 
consumption are normalized to ADP stimulated respiration in the absence of PEtn. Data are 
representative of three independent trials. Error bars represent deviation from a linear fit when 
corresponding slopes were analyzed. (B) Simultaneous measurements of oxygen consumption, 
membrane potential, NADH and FAD+ fluorescence. Purified mouse kidney mitochondria (0.35 
mg/ml) and TMRM (0.5 µM) were incubated in buffer A (137 mM KCl, 10 mM HEPES pH 7.4, 
2.5 mM MgCl2, 0.1% BSA). Glutamate/malate (G/M) (4.6 mM), ADP (180 µM) and PEtn (0, 
3.2, and 8 mM) were added at the time points indicated by arrows. Traces are representative of at 
least three independent experiments. (C) For traces showing oxygen consumption in the presence 
of PCho the assay mixture contained mouse kidney mitochondria (0.2 mg/ml) in buffer A. The 
respiratory substrates glutamate/malate (G/M) (4.6 mM), ADP (200 µM) and phosphocholine 
(PCho) (0, 3 mM and 8 mM) were added at the time points indicated by arrows. Traces are 
representative of three independent experiments. 
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Meclizine Treatment Does Not Alter Steady State Levels of Mitochondrial PE 
 Recently, it has been shown that a modest reduction in PE in mammalian 
mitochondria impairs oxidative phosphorylation, reducing respiration (Tasseva et al., 
2013). Therefore, we asked if short-term (5 h) inhibition of the Kennedy pathway of PE 
synthesis by meclizine causes a decrease in cellular and mitochondrial PE levels and 
contributes to reduced respiration. As shown in Fig. 4.6A and B, we did not observe a 
significant decrease in the cellular or mitochondrial PE levels of human fibroblasts 
treated with meclizine, ruling out a reduction in PE as a cause for decreased respiration 
in vivo. 
Figure 4.6 Total cellular and mitochondrial phosphatidylethanolamine levels in meclizine 
treated fibroblasts. 
MCH58 fibroblasts were grown in the presence of Meclizine (50 µM) or DMSO for 5 h, 
followed by (A) cellular and (B) mitochondrial phospholipid extraction as described under 
“Experimental Procedures.” Phospholipids were separated using one-dimensional TLC and 
phosphorous was quantified using the Bartlett method. Data are expressed as the percentage of 
PE relative to total phospholipids and represent the average of three independent experiments 
(NS: not significant). 
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Inhibition of Respiratory Growth by Meclizine Is Accentuated through Addition of 
Ethanolamine 
 We originally identified meclizine as an agent that inhibits the growth of human 
skin fibroblasts grown in galactose versus glucose. It has long been known that when 
human cells are grown in galactose, they are highly reliant on mitochondrial respiration. 
In the current study, we have shown that in the presence of meclizine, the phospholipid 
biosynthetic intermediate PEtn accumulates and directly inhibits mitochondrial 
respiration. Our model predicts that exogenous Etn should have an additive or 
synergistic effect with meclizine in inhibiting respiratory growth. Consistent with our 
model, we found that a combination of meclizine treatment with Etn supplementation 
synergistically reduced cellular ATP levels (Fig. 4.7). 
Figure 4.7 Meclizine mediated respiratory growth inhibition of human skin fibroblasts is 
enhanced by exogenous addition of ethanolamine. 
MCH58 cells cultured in 10 mM galactose medium were exposed to different concentrations of 
meclizine and Etn for 24 h followed by the measurement of cellular ATP levels. Data was 
normalized to 100% for no treatment controls and errors bars represent standard deviation from 
mean (n=3). 
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Discussion 
The current study provides the molecular basis for inhibition of respiration by 
meclizine, an over-the-counter anti-nausea and anti-vertigo drug. Using a combination of 
mass spectrometry, metabolic labeling and in vitro biochemical assays we found that 
CTP:phosphoethanolamine cytidylyltransferase (PCYT2) is a direct target of meclizine. 
Our study highlights the use of metabolic profiling in deciphering mechanisms of drug 
action, with important biological and clinical implications. 
To our knowledge, this study is the first to pharmacologically link the Kennedy 
pathway of PE biosynthesis to mitochondrial energy metabolism and is consistent with a 
previous report showing that mice heterozygous for the Pcyt2 gene have reduced energy 
production from fatty acid oxidation (Fullerton et al., 2009). PE is an essential 
phospholipid present in eukaryotic membranes and is highly enriched in mitochondrial 
membranes. It has overlapping functions with cardiolipin (Gohil et al., 2005), a 
mitochondria-specific phospholipid that is essential for optimal respiration (Jiang et al., 
2000). PE is synthesized by multiple biochemical pathways (Vance, 2008; Pavlovic and 
Bakovic, 2013), including the phosphatidylserine decarboxylase catalyzed mitochondrial 
pathway and the cytosolic/ER CDP-Etn Kennedy pathway. The mitochondrial pathway 
contributes the bulk of mitochondrial PE that is retained in this organelle and contributes 
to mitochondrial function (Steenbergen et al., 2005; Bleijerveld et al., 2007). Recently, it 
has been shown that a decrease in mitochondrial PE by deletion of phosphatidylserine 
decarboxylase in the yeast S. cerevisiae results in reduced respiration (Bottinger et al., 
2012). Similar reduction in mitochondrial respiration has been observed in mammalian 
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cells where mitochondrial phosphatidylserine decarboxylase is depleted (Tasseva et al., 
2013). However, the non-mitochondrial CDP-Etn Kennedy pathway of PE synthesis has 
never been linked to respiratory defect either in yeast or mammalian cells. 
How does direct inhibition of PCYT2 lead to attenuation of mitochondrial 
respiration? Two possibilities exist: (1) the accumulation of upstream metabolites (PEtn) 
could interfere with mitochondrial respiration or (2) depletion of downstream 
metabolites (PE) could alter mitochondrial membrane structure thereby inhibiting 
respiration. We favor the first hypothesis, which is supported by our observation that the 
intracellular concentration of PEtn in meclizine treated fibroblasts increases to a level 
sufficient to inhibit mitochondrial respiration (Figs. 4.1D and 4.5A and B). Notably, our 
in vitro data on PEtn inhibition of mitochondrial respiration is consistent with a previous 
study that showed both Etn and PEtn inhibit respiration in isolated mitochondria 
(Modica-Napolitano and Renshaw, 2004). The second mechanism seems less likely 
since the bulk of mitochondrial PE is synthesized in situ by the action of 
phosphatidylserine decarboxylase. Moreover, we did not observe any decrease in 
cellular mitochondrial PE of the meclizine treated fibroblasts discounting the second 
possibility (Fig. 4.6). The synthetic interaction between meclizine and Etn in MCH58 
cells further buttress the first model, since addition of Etn to meclizine treated cells 
exacerbated, rather than alleviated, the cell viability as measured by ATP levels (Fig. 
4.7).  
According to our model, meclizine itself has no effect on mitochondria, but 
rather blocks PCYT2, leading to the accumulation of PEtn, which is itself an endogenous 
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inhibitor of respiration. Although multiple lines of evidence support our model, 
questions still remain. First the genetic depletion of PCYT2 by RNAi did not completely 
phenocopy meclizine’s effect on mitochondrial respiration, though this could be due to 
incomplete knockdown and the lack of sustained accumulation of PEtn (Fig. 4.4E). The 
inability of genetic silencing to fully phenocopy drug treatment is not uncommon (Weiss 
et al., 2007), and in principle could be due to the presence of residual enzyme activity of 
PCYT2. Second, overexpression of PCYT2 did not confer resistance to meclizine’s 
effect on respiration (data not shown), which could be due to tight regulation of its 
intracellular levels. Given that meclizine is known to target multiple cellular proteins 
(Cohen and DeJong, 1972; Huang et al., 2004; Kubo et al., 1987), we cannot exclude 
additional mechanisms that may underlie its impact on respiration.  
Regardless, we have clearly shown that meclizine inhibits PCYT2 and causes an 
increase in cytosolic PEtn to a level sufficient to inhibit mitochondrial respiration. To 
our knowledge, such a mechanism of respiratory inhibition has never been described 
before. The mechanism of PEtn-mediated inhibition of respiration appears to be distinct 
from canonical inhibitors of respiration, including inhibitors of electron transport 
(rotenone, antimycin), uncouplers (CCCP, dinitrophenol) and ATP synthesis 
(oligomycin). PEtn addition to mitochondria resulted in reduced oxygen consumption, 
diminished membrane potential and a decrease in NADH levels (Fig. 4.5), whereas 
treatment with rotenone or antimycin would have increased NADH levels, CCCP would 
have increased oxygen consumption, and oligomycin would have increased membrane 
potential. The inhibition does not appear to be substrate specific, as we observed 
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inhibition of respiration using complex I or complex II linked substrates. The precise 
mechanism by which accumulation of cytosolic PEtn inhibits respiration is currently not 
known, but our bioenergetics measurements suggest a mechanism whereby PEtn may 
interfere with the generation of reducing equivalents that feed into the respiratory chain. 
Importantly, our work identifies for the first time an inhibitor of the CDP-Etn 
Kennedy pathway with therapeutic potential. This pathway has been implicated in a 
range of human disorders including cancer (Ferreira et al., 2012), ischemia-reperfusion 
injury of brain and heart (Kelly et al., 2010), as well as infectious disorders including 
African sleeping sickness and malaria (Gibellini et al., 2009, Maheshwari et al., 2013). 
Our own previous work has shown that meclizine, through blunting of respiration, is 
cytoprotective against ischemic injury to the brain and the heart (Gohil et al., 2010) as 
well as polyQ toxicity observed in Huntington’s disease (Gohil et al., 2011). Currently, 
effective therapies are not available for these disorders, making meclizine an attractive 
drug for repurposing. An intriguing question is to what extent the anti-vertigo and anti-
nausea effects of meclizine may be occurring through targeting of PCYT2. A recent 
pharmacokinetics study on human subjects given an oral dose of 25 mg result in a peak 
plasma concentration of 80 ng/ml (~0.2 µM) (Wang et al., 2012), which is almost 70 
fold below the minimum concentration required for inhibition of respiration in cell lines 
we have tested (Gohil et al., 2010), thus currently approved doses are unlikely to be 
active on mitochondrial respiration. We anticipate that identification of PCYT2 as a 
direct molecular target of meclizine may help to guide its clinical development for new 
uses. It is notable that PEtn, which accumulates following inhibition, can be detected 
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noninvasively using phosphorus 31P-NMR, providing a facile marker of 
pharmacodynamics.  
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CHAPTER V  
SUMMARY AND CONCLUSIONS 
Summary 
 My work is focused on understanding how mitochondrial membrane 
phospholipid composition impacts mitochondrial function by influencing the biogenesis 
of the mitochondrial respiratory chain (MRC). I examined the role of the most abundant 
mitochondrial phospholipids, phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
and cardiolipin (CL) in MRC function and formation. I showed a specific requirement of 
mitochondrial PE for MRC complex III and IV activities. Additionally, I found that CL 
is specifically required for MRC supercomplex formation in vivo. While the non-bilayer 
forming phospholipids PE and CL have specific roles in MRC function and formation, 
PC is redundant for mitochondrial bioenergetics. Furthermore, I assessed the ability of 
PE synthesized outside of the mitochondria, from exogenous ethanolamine (Etn), to 
compensate for the depletion of mitochondrial PE. I showed that PE synthesized outside 
of the mitochondria is imported into the mitochondria where it functionally substitutes 
for the lack of mitochondrial PE synthesis. This finding suggest the existence of a 
mitochondrial PE import pathway, which can be utilized to manipulate MRC function by 
altering mitochondrial PE levels. PE and CL are both cone-shaped, non-bilayer forming 
phospholipids that have been proposed to have overlapping functions (Gohil et al., 2005; 
Osman et al., 2009). I tested this proposition by elevating mitochondrial PE with 
exogenous Etn supplementation in a CL deficient yeast model. Indeed, I found that Etn 
supplementation rescued the respiratory growth of CL deficient cells, but surprisingly, 
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Etn-mediated rescue was independent of PE biosynthesis and solely dependent on 
supplementation with the soluble phospholipid precursors - Etn and propanolamine. In 
order to determine the biochemical basis for Etn-mediated growth rescue of CL deficient 
cells, I examined MRC function and formation in CL mutants grown in the presence of 
exogenous Etn. I found that Etn supplementation restores mitochondrial respiratory 
chain supercomplex assembly and reduces oxidative stress in CL deficient taz1Δ cells – 
a yeast model of Barth syndrome. Interestingly, Etn supplementation fails to rescue 
supercomplex formation in crd1Δ cells that are completely devoid of CL, suggesting that 
supercomplex formation requires a critical amount of CL. I determined that Etn 
supplementation rescued MRC complex IV activity and ameliorated oxidative stress in 
crd1Δ cells, suggesting that these phenotypes are independent of supercomplex 
formation. These findings describe a novel role of Etn in mitochondrial physiology and 
support a link between Kennedy pathway metabolites and mitochondrial function. In line 
with this observation, we found that blocking the Etn-Kennedy pathway of PE 
biosynthesis by meclizine, a clinically used anti-nausea drug, attenuates MRC function. I 
worked in collaboration with Dr. Vamsi Mootha’s team at the Massachusetts General 
Hospital, Boston to determine that meclizine-mediated attenuation of mitochondrial 
respiration was not due to depleted mitochondrial PE levels, but most likely due to the 
cellular accumulation of phosphoethanolamine, a PE intermediate. Taken together, my 
work highlights the specific roles of non-bilayer forming phospholipids in MRC function 
and formation and suggests new roles of the Kennedy pathway PE precursors Etn and 
PEtn in modulating mitochondrial function. 
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Future Directions 
One major outcome of my work was the finding that non-mitochondrial PE can 
be imported into the mitochondria, where it can functionally substitute for the lack of 
mitochondrial PE biosynthesis. The mechanism by which non-mitochondrial PE is 
imported into the mitochondria is yet to be determined and represents an important goal 
for future studies. Based on the recent discoveries in cell biology about the existence of 
membrane contact sites between mitochondria, ER, and vacuoles, I predict that the 
contact site protein complexes will likely play a role in the mitochondrial PE import. 
This can be examined using a candidate-based approach that involves genetically 
deleting components of membrane contact sites between the mitochondria and other 
organelles in psd1∆ cells and attempting a rescue of the double mutant by Etn 
supplementation. A lack of rescue of the double mutant in respiratory growth medium 
will suggest a potential role of the candidate gene in mitochondrial PE import.  
 Intra-organelle phospholipid transport processes are still poorly understood and 
one of the major unanswered questions in mitochondrial membrane biogenesis is how 
the PE substrate PS is transported from the ER to the mitochondria. A genome-scale Etn-
sensitized screen involving the combination of a DNA barcoded yeast deletion mutant 
library and next generation sequencing could be used to identify the PS transporter 
protein(s). The screen will be based on the idea that cells lacking in the PS transporter 
will phenocopy psd1∆ cells, in that they will be respiratory deficient and their 
respiratory deficiency will be overcome by stimulating non-mitochondrial PE 
biosynthesis by Etn supplementation. To identify deletion strains that contain defects in 
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mitochondrial respiration, the deletion pool will be grown in either MRC-dependent 
conditions (SC lactate) or MRC-independent conditions (SC glucose). Deletion strains 
that show a severe growth defect in SC lactate media and are rescued by Etn 
supplementation will be considered candidate genes for putative involvement in 
mitochondrial PS import. 
Another important question that emerged from my studies regards the novel role 
of Etn in attenuating MRC function in CL deficient yeast cells. Future studies focused on 
identifying the mechanism by which Etn mediates the rescue of CL depleted cells would 
require a multi-prong approach involving genetics, genomics, and metabolomics. In my 
initial attempts to unravel the mechanism of Etn-mediated rescue of CL deficiency, I 
utilized a candidate-based genetic approach where I deleted candidate genes in a taz1∆ 
background in an attempt to disrupt Etn-mediated rescue (Figs. A-1 and A-2B). The 
candidate genes were selected based on their putative role in the incorporation of Etn 
into cellular metabolites, including N-acylethanolamines and polyamines. Future studies 
will be driven by mass spectrometry based non-targeted metabolic profiling, an unbiased 
approach to identify relative changes in metabolites of Etn treated versus untreated cells. 
Heavy isotope labeled Etn could also be utilized in an attempt to follow Etn into the cell 
or its incorporation into other metabolites that are mediating the rescue. In addition, a 
synthetic genetic array of crd1∆ cells crossed with all of the viable yeast deletion strains 
could be utilized to screen for the loss of Etn-mediated rescue. Identification of genes 
that participate in Etn-mediated rescue will provide clues for the underlying mechanism 
of the observed rescue.  
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APPENDIX A  
ETHANOLAMINE-MEDIATED RESCUE OF CL DEPLETED CELLS  
 I showed that Etn supplementation rescues the mitochondrial defects observed in 
CL depleted cells independent of its incorporation into PE. The mechanism underlying 
Etn-mediated rescue remains elusive. One possible candidate that contains the Etn 
moiety is N-acyl phosphatidylethanolamine (NAPE). NAPE is formed by acylation of 
PE and is and proposed to have a cytoprotective effects in yeast cells (Merkel et al., 
2005). Two enzymes believed to be required for NAPE metabolism are Fmp30, a 
phospholipase D, and Amd2, a putative amidase. In order to determine if these enzymes 
were involved in the Etn-mediated rescue of CL depleted cells, I constructed the double 
knockouts taz1Δamd2Δ and taz1Δfmp30Δ and tested for a rescue of growth with Etn 
supplementation. These strains were both rescued by Etn, suggesting that NAPE is not 
required for Etn-mediated rescue (Fig. A-1). 
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Figure A-1 Amd2 and Fmp30 are not required for the Etn-mediated rescue of CL 
deficiency.  
(A) The growth of WT, taz1Δ, amd2Δ, taz1Δamd2Δ and (B) taz1Δ, fmp30Δ, taz1Δfmp30Δ cells 
at 37°C in SC ethanol and SC ethanol + 2 mM Etn media was monitored by measuring 
absorbance at 600 nm. Data are representative of at least two independent measurements. 
 
The polyamine spermidine is an abundant cellular metabolite that contains amine 
groups (Fig. A-2A). The biosynthetic enzyme responsible for synthesizing spermidine in 
yeast is Spe3. In order to determine if Etn mediated its rescue by incorporation into 
spermidine via Spe3, I monitored the ability of Etn to rescue of taz1Δspe3Δ cells. Etn 
rescued the growth of these cells, suggesting that Spe3 does not mediate the rescue of 
CL deficient cells (Fig. A-2B). Interestingly, spermidine has been shown to be imported 
into the mitochondria (Toninello et al., 1992) and has been found to enhance mitophagy 
and mitochondrial respiration (Eisenberg et al., 2016). I examined the ability of 
spermidine to rescue CL deficient cells and found that this polyamine rescued 
respiratory growth similar to Etn (Fig. A-2C). It is possible that these amine-containing 
molecules utilize the same underlying mechanism to mediate the rescue of CL 
deficiency. 
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Figure A-2 Spermidine rescues the growth of CL deficient cells. 
(A) The molecular structure of spermidine. (B) The growth of WT, taz1Δ, spe3Δ, taz1Δspe3Δ 
cells cultured at 37°C in SC ethanol and SC ethanol + 2 mM Etn media was monitored by 
measuring absorbance at 600 nm. Data are representative of at least two independent 
measurements. (C) The growth of WT, taz1Δ, and crd1Δ cells cultured at 30°C (upper panel) and 
37°C (lower panel) in SC ethanol, SC ethanol + 2 mM Etn and SC ethanol + 2 mM spermidine 
(Spd) media was monitored by measuring absorbance at 600 nm. Data are representative of at 
least three independent measurements. 
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APPENDIX B  
MECLIZINE-MEDIATED RESPIRATORY INHIBITION IN SACCHAROMYCES 
CEREVISIAE 
 I showed that meclizine inhibits respiratory growth in S. cerevisiae, suggesting 
that attenuation of respiration by meclizine is conserved from mammals to yeast. 
Meclizine inhibited the growth of yeast cells in non-fermentable, synthetic lactate 
medium, without affecting growth in glucose-containing medium (Fig. B-1A). 
Interestingly, stimulation of the Kennedy pathway by Etn supplementation 
further enhanced the growth defect (Fig. B-1A), suggesting that the effect of 
meclizine on mitochondrial energy metabolism is mediated by phosphoethanolamine 
build-up due to the inhibition of the Etn branch of the Kennedy pathway. Similar to our 
observations in PCYT2 knockdown cells, we found that ect1Δ cells do not phenocopy the 
effect of meclizine on respiratory growth (Fig. B-1B), suggesting that meclizine may 
attenuate MRC function independent of PEtn build-up.  
Figure B-1 Meclizine-mediated respiratory inhibition is conserved in yeast.  
(A) Growth of S. cerevisiae in the presence of indicated dose of meclizine, 5 mM choline (Cho) 
and 5 mM ethanolamine (Etn) was monitored for 4 days before the images were captured. (B) 
Growth of Ect1Δ cells in the indicated media was monitored for 4 days. 
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